Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	aspartic-type endopeptidase activity	ERVK-6 ERVK-7 ERVK-9 ERVK-10 ERVK-19 ERVK-24 ERVK-8	8.32e-08	37	204	7	GO:0004190
GeneOntologyMolecularFunction	aspartic-type peptidase activity	ERVK-6 ERVK-7 ERVK-9 ERVK-10 ERVK-19 ERVK-24 ERVK-8	1.01e-07	38	204	7	GO:0070001
GeneOntologyMolecularFunction	RNA-DNA hybrid ribonuclease activity	ERVK-6 ERVK-7 ERVK-10 ERVK-8	3.30e-06	11	204	4	GO:0004523
GeneOntologyMolecularFunction	RNA-directed DNA polymerase activity	ERVK-6 ERVK-7 ERVK-10 ERVK-8	9.77e-06	14	204	4	GO:0003964
GeneOntologyMolecularFunction	catalytic activity, acting on DNA	ERVK-6 CHD1 ERVK-7 ERVK-10 TOP1MT EP400 WRN RFC1 TEFM ERVK-8 POLG2 TOP1	1.70e-05	262	204	12	GO:0140097
GeneOntologyMolecularFunction	ATP-dependent activity	CFTR PEX6 CHD1 MDN1 DDX43 DNHD1 KIF13B HYOU1 EP400 DNAH10 DYNC2H1 WRN RNF213 RFC1 ABCC6 ABCA5 DYNC1LI1 MACF1 DNAH11	1.87e-05	614	204	19	GO:0140657
GeneOntologyMolecularFunction	minus-end-directed microtubule motor activity	DNHD1 DNAH10 DYNC2H1 DNAH11	2.89e-05	18	204	4	GO:0008569
GeneOntologyMolecularFunction	dynein intermediate chain binding	SPTBN5 DNHD1 DNAH10 DYNC2H1 DNAH11	3.54e-05	37	204	5	GO:0045505
GeneOntologyMolecularFunction	DNA polymerase activity	ERVK-6 ERVK-7 ERVK-10 ERVK-8 POLG2	4.04e-05	38	204	5	GO:0034061
GeneOntologyMolecularFunction	ATP hydrolysis activity	CFTR PEX6 CHD1 MDN1 DDX43 KIF13B DNAH10 DYNC2H1 WRN RNF213 RFC1 ABCC6 ABCA5 MACF1 DNAH11	5.08e-05	441	204	15	GO:0016887
GeneOntologyMolecularFunction	RNA stem-loop binding	ERVK-6 ERVK-7 ERVK-10 ERVK-8	5.52e-05	21	204	4	GO:0035613
GeneOntologyMolecularFunction	microtubule motor activity	DNHD1 KIF13B DNAH10 DYNC2H1 DYNC1LI1 DNAH11	8.04e-05	70	204	6	GO:0003777
GeneOntologyMolecularFunction	chondroitin hydrolase activity	HYAL4 HYAL1	1.04e-04	2	204	2	GO:0052757
GeneOntologyMolecularFunction	endogalactosaminidase activity	HYAL4 HYAL1	1.04e-04	2	204	2	GO:0033931
GeneOntologyMolecularFunction	3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity	FUT3 FUT5	1.04e-04	2	204	2	GO:0017060
GeneOntologyMolecularFunction	zinc ion binding	ERVK-6 TRIML2 ERVK-7 ERVK-9 ERVK-10 ACE FBXO30 BRCA1 RTL3 SUPT4H1 ERVK-19 DMD ERVK-24 NQO2 DPYS DRP2 DTX1 CPA2 CPB1 SIRT6 LTN1 ERVK-8	1.22e-04	891	204	22	GO:0008270
GeneOntologyMolecularFunction	dynein light intermediate chain binding	DNHD1 DNAH10 DYNC2H1 DNAH11	1.79e-04	28	204	4	GO:0051959
GeneOntologyMolecularFunction	vinculin binding	DMD TLN1 SORBS3	2.79e-04	13	204	3	GO:0017166
GeneOntologyMolecularFunction	bicarbonate transmembrane transporter activity	SLC26A4 CFTR BEST4 SLC4A10	3.04e-04	32	204	4	GO:0015106
GeneOntologyMolecularFunction	DNA polymerase processivity factor activity	TEFM POLG2	3.10e-04	3	204	2	GO:0030337
GeneOntologyMolecularFunction	transition metal ion binding	ERVK-6 TRIML2 CYP21A2 ERVK-7 ERVK-9 ERVK-10 ACE FBXO30 BRCA1 RTL3 SUPT4H1 ERVK-19 DMD ERVK-24 NQO2 DPYS DRP2 DTX1 WRN CPA2 CPB1 SIRT6 LTN1 ERVK-8 SOD2	4.90e-04	1189	204	25	GO:0046914
GeneOntologyMolecularFunction	RNA endonuclease activity, producing 5'-phosphomonoesters	ERVK-6 ERVK-7 ERVK-10 ERVK-8	5.36e-04	37	204	4	GO:0016891
GeneOntologyMolecularFunction	DNA topoisomerase type I (single strand cut, ATP-independent) activity	TOP1MT TOP1	6.15e-04	4	204	2	GO:0003917
GeneOntologyMolecularFunction	dynein heavy chain binding	DNALI1 DYNC2I2 DYNC1LI1	6.43e-04	17	204	3	GO:0045504
GeneOntologyMolecularFunction	isomerase activity	RGPD4 CFTR RGPD3 TOP1MT RGPD8 WRN PGM2 TOP1	8.24e-04	192	204	8	GO:0016853
GeneOntologyMolecularFunction	structural molecule activity	ERVK-6 CLTCL1 ERVK-7 ERVK-9 ERVK-10 CLTC ERVK-19 DLG3 NTN1 DMD ERVK-24 CAPN3 LAMB1 RPL14 TLN1 SORBS3 ERVK-8 MACF1 MRPL9 EPB42	8.35e-04	891	204	20	GO:0005198
GeneOntologyMolecularFunction	nucleotidyltransferase activity	ERVK-6 ERVK-7 ERVK-10 NMNAT1 SIRT6 ERVK-8 POLG2	9.73e-04	152	204	7	GO:0016779
GeneOntologyMolecularFunction	catalytic activity, acting on a nucleic acid	ERVK-6 CHD1 ERVK-7 ERVK-10 DDX43 TOP1MT TARBP1 TRMT12 EP400 WRN RFC1 TEFM PCIF1 ERVK-8 POLG2 TOP1	1.00e-03	645	204	16	GO:0140640
GeneOntologyMolecularFunction	pyrophosphatase activity	CFTR PEX6 CHD1 MDN1 GNL2 DDX43 KIF13B DNAH10 DYNC2H1 WRN RNF213 RFC1 NKIRAS1 ABCC6 OPA1 NUDT6 ABCA5 MACF1 DNAH11	1.02e-03	839	204	19	GO:0016462
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides	CFTR PEX6 CHD1 MDN1 GNL2 DDX43 KIF13B DNAH10 DYNC2H1 WRN RNF213 RFC1 NKIRAS1 ABCC6 OPA1 NUDT6 ABCA5 MACF1 DNAH11	1.03e-03	840	204	19	GO:0016817
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides	CFTR PEX6 CHD1 MDN1 GNL2 DDX43 KIF13B DNAH10 DYNC2H1 WRN RNF213 RFC1 NKIRAS1 ABCC6 OPA1 NUDT6 ABCA5 MACF1 DNAH11	1.03e-03	840	204	19	GO:0016818
GeneOntologyMolecularFunction	ribonucleoside triphosphate phosphatase activity	CFTR PEX6 CHD1 MDN1 GNL2 DDX43 KIF13B DNAH10 DYNC2H1 WRN RNF213 RFC1 NKIRAS1 ABCC6 OPA1 ABCA5 MACF1 DNAH11	1.04e-03	775	204	18	GO:0017111
GeneOntologyMolecularFunction	SUMO ligase activity	RGPD4 RGPD3 RGPD8	1.05e-03	20	204	3	GO:0061665
GeneOntologyMolecularFunction	endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters	ERVK-6 ERVK-7 ERVK-10 ERVK-8	1.23e-03	46	204	4	GO:0016893
GeneOntologyMolecularFunction	cytoskeletal motor activity	DNHD1 KIF13B DNAH10 DYNC2H1 DYNC1LI1 DNAH11	1.35e-03	118	204	6	GO:0003774
GeneOntologyMolecularFunction	4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase activity	FUT3 FUT5	1.52e-03	6	204	2	GO:0017083
GeneOntologyMolecularFunction	cargo receptor activity	TMED6 LRP1B TMED4 CD44 TMED9	1.79e-03	85	204	5	GO:0038024
GeneOntologyMolecularFunction	clathrin light chain binding	CLTCL1 CLTC	2.11e-03	7	204	2	GO:0032051
GeneOntologyMolecularFunction	acyltransferase activity	RGPD4 TRIML2 DDB2 FBXO30 FASN FBXO4 BRCA1 RGPD3 MED23 RGPD8 DTX1 RNF213 SIRT6 CS LTN1 PNPLA3 EPB42	2.60e-03	775	204	17	GO:0016746
GeneOntologyMolecularFunction	endonuclease activity	ERVK-6 ERVK-7 ERVK-10 TEFM ERVK-8 LAS1L	2.77e-03	136	204	6	GO:0004519
GeneOntologyMolecularFunction	alpha-(1->3)-fucosyltransferase activity	FUT3 FUT5	2.79e-03	8	204	2	GO:0046920
GeneOntologyMolecularFunction	DNA topoisomerase activity	TOP1MT TOP1	2.79e-03	8	204	2	GO:0003916
GeneOntologyBiologicalProcess	intracellular transport	MON2 RGPD4 ERVK-6 GPRASP1 TMED6 CLTCL1 TBC1D5 PEX6 PEX7 SPTBN5 MDN1 BRCA1 GLP1R RGPD3 CLTC NTN1 RGPD5 KIF13B CDC42BPA HYOU1 RGPD8 DYNC2I2 DYNC2H1 SYNE1 AHCTF1 FERMT1 SIRT6 OPA1 NPLOC4 SPAG5 TMED4 TRAM1L1 DYNC1LI1 TMED9	3.08e-06	1496	201	34	GO:0046907
GeneOntologyBiologicalProcess	DNA integration	ERVK-6 ERVK-7 ERVK-10 ERVK-8	5.84e-06	13	201	4	GO:0015074
GeneOntologyBiologicalProcess	DNA-templated DNA replication	ERVK-6 ERVK-7 ERVK-10 BRCA1 WRN RFC1 ZNF365 TEFM ERVK-8 POLG2	1.02e-05	178	201	10	GO:0006261
GeneOntologyBiologicalProcess	cell-cell fusion	ERVK-6 ERVK-9 PTGFRN ERVK-19 DOCK1 ERVK-8 CD44	1.95e-05	85	201	7	GO:0140253
GeneOntologyBiologicalProcess	syncytium formation by plasma membrane fusion	ERVK-6 ERVK-9 PTGFRN ERVK-19 DOCK1 ERVK-8 CD44	1.95e-05	85	201	7	GO:0000768
GeneOntologyBiologicalProcess	syncytium formation	ERVK-6 ERVK-9 PTGFRN ERVK-19 DOCK1 ERVK-8 CD44	2.64e-05	89	201	7	GO:0006949
GeneOntologyBiologicalProcess	NLS-bearing protein import into nucleus	RGPD4 RGPD3 RGPD5 RGPD8	3.75e-05	20	201	4	GO:0006607
GeneOntologyBiologicalProcess	DNA replication	ERVK-6 ERVK-7 ERVK-10 BRCA1 TOP1MT WRN RFC1 ZNF365 TEFM ERVK-8 POLG2 TOP1	5.92e-05	312	201	12	GO:0006260
GeneOntologyBiologicalProcess	positive regulation of glucokinase activity	RGPD4 RGPD3 RGPD8	7.33e-05	9	201	3	GO:0033133
GeneOntologyBiologicalProcess	DNA synthesis involved in DNA repair	ERVK-6 ERVK-7 ERVK-10 WRN ERVK-8	1.02e-04	48	201	5	GO:0000731
GeneOntologyBiologicalProcess	positive regulation of hexokinase activity	RGPD4 RGPD3 RGPD8	1.04e-04	10	201	3	GO:1903301
GeneOntologyBiologicalProcess	RNA-templated DNA biosynthetic process	ERVK-6 ERVK-7 ERVK-10 FBXO4 RFC1 ERVK-8	1.61e-04	83	201	6	GO:0006278
GeneOntologyBiologicalProcess	carbohydrate biosynthetic process	RGPD4 PTH1R RGPD3 CLTC NDST1 RGPD8 SIRT6 FUT3 FUT5 PGM2	1.62e-04	247	201	10	GO:0016051
GeneOntologyCellularComponent	dynein complex	DNALI1 DNHD1 DYNC2I2 DNAH10 DYNC2H1 DYNC1LI1 DNAH11	9.44e-07	54	205	7	GO:0030286
GeneOntologyCellularComponent	microtubule associated complex	DNALI1 SPTBN5 DNHD1 KIF13B DYNC2I2 DNAH10 DYNC2H1 DYNC1LI1 DNAH11	3.11e-05	161	205	9	GO:0005875
GeneOntologyCellularComponent	cytoplasmic periphery of the nuclear pore complex	RGPD4 RGPD3 RGPD8	5.02e-05	8	205	3	GO:1990723
GeneOntologyCellularComponent	nuclear pore cytoplasmic filaments	RGPD4 RGPD3 RGPD8	1.06e-04	10	205	3	GO:0044614
GeneOntologyCellularComponent	annulate lamellae	RGPD4 RGPD3 RGPD8	3.12e-04	14	205	3	GO:0005642
Domain	AAA	CFTR PEX6 MDN1 DNAH10 DYNC2H1 RNF213 RFC1 ABCC6 ABCA5 DNAH11	3.06e-06	144	197	10	SM00382
Domain	AAA+_ATPase	CFTR PEX6 MDN1 DNAH10 DYNC2H1 RNF213 RFC1 ABCC6 ABCA5 DNAH11	3.06e-06	144	197	10	IPR003593
Domain	Spectrin	SPTBN5 DMD DRP2 SYNE1 MACF1	3.58e-06	23	197	5	PF00435
Domain	Grip	RGPD4 RGPD3 RGPD5 RGPD8	3.74e-06	11	197	4	SM00755
Domain	GRIP	RGPD4 RGPD3 RGPD5 RGPD8	3.74e-06	11	197	4	PF01465
Domain	Ran_BP1	RGPD4 RGPD3 RGPD5 RGPD8	5.56e-06	12	197	4	PF00638
Domain	RANBD1	RGPD4 RGPD3 RGPD5 RGPD8	5.56e-06	12	197	4	PS50196
Domain	GRIP_dom	RGPD4 RGPD3 RGPD5 RGPD8	5.56e-06	12	197	4	IPR000237
Domain	GRIP	RGPD4 RGPD3 RGPD5 RGPD8	5.56e-06	12	197	4	PS50913
Domain	RanBD	RGPD4 RGPD3 RGPD5 RGPD8	7.97e-06	13	197	4	SM00160
Domain	Ran_bind_dom	RGPD4 RGPD3 RGPD5 RGPD8	7.97e-06	13	197	4	IPR000156
Domain	Dynein_HC_stalk	DNHD1 DNAH10 DYNC2H1 DNAH11	1.11e-05	14	197	4	IPR024743
Domain	Dynein_heavy_dom-2	DNHD1 DNAH10 DYNC2H1 DNAH11	1.11e-05	14	197	4	IPR013602
Domain	DHC_N2	DNHD1 DNAH10 DYNC2H1 DNAH11	1.11e-05	14	197	4	PF08393
Domain	ATPase_dyneun-rel_AAA	MDN1 DNAH10 DYNC2H1 DNAH11	1.11e-05	14	197	4	IPR011704
Domain	MT	DNHD1 DNAH10 DYNC2H1 DNAH11	1.11e-05	14	197	4	PF12777
Domain	AAA_5	MDN1 DNAH10 DYNC2H1 DNAH11	1.11e-05	14	197	4	PF07728
Domain	Spectrin_repeat	SPTBN5 DMD DRP2 SYNE1 MACF1	1.20e-05	29	197	5	IPR002017
Domain	DHC_fam	DNHD1 DNAH10 DYNC2H1 DNAH11	1.50e-05	15	197	4	IPR026983
Domain	Dynein_heavy	DNHD1 DNAH10 DYNC2H1 DNAH11	1.50e-05	15	197	4	PF03028
Domain	Dynein_heavy_dom	DNHD1 DNAH10 DYNC2H1 DNAH11	1.50e-05	15	197	4	IPR004273
Domain	SPEC	SPTBN5 DMD DRP2 SYNE1 MACF1	1.98e-05	32	197	5	SM00150
Domain	Spectrin/alpha-actinin	SPTBN5 DMD DRP2 SYNE1 MACF1	1.98e-05	32	197	5	IPR018159
Domain	Rab_bind	RGPD4 RGPD3 RGPD8	3.92e-05	7	197	3	PF16704
Domain	GCC2_Rab_bind	RGPD4 RGPD3 RGPD8	3.92e-05	7	197	3	IPR032023
Domain	-	CFTR PEX6 CHD1 MDN1 GNL2 DLG3 DDX43 DNHD1 NDST1 EP400 DNAH10 DYNC2H1 WRN RNF213 RFC1 NKIRAS1 ABCC6 OPA1 ABCA5 DYNC1LI1 DNAH11	4.27e-05	746	197	21	3.40.50.300
Domain	DHC_N1	DNAH10 DYNC2H1 DNAH11	6.22e-05	8	197	3	PF08385
Domain	TMP21-related	TMED6 TMED4 TMED9	6.22e-05	8	197	3	IPR015720
Domain	Dynein_heavy_dom-1	DNAH10 DYNC2H1 DNAH11	6.22e-05	8	197	3	IPR013594
Domain	ARM-type_fold	MON2 GPRASP1 CLTCL1 APC2 MROH5 CLTC TARBP1 EIF3M DOCK1 MROH2A MROH2B LTN1 PRKDC	6.66e-05	339	197	13	IPR016024
Domain	ACTININ_2	SPTBN5 DMD SYNE1 MACF1	9.09e-05	23	197	4	PS00020
Domain	ACTININ_1	SPTBN5 DMD SYNE1 MACF1	9.09e-05	23	197	4	PS00019
Domain	Actinin_actin-bd_CS	SPTBN5 DMD SYNE1 MACF1	9.09e-05	23	197	4	IPR001589
Domain	EMP24_GP25L	TMED6 TMED4 TMED9	9.26e-05	9	197	3	SM01190
Domain	P-loop_NTPase	CFTR PEX6 CHD1 MDN1 GNL2 DLG3 DDX43 DNHD1 KIF13B NDST1 EP400 DNAH10 DYNC2H1 WRN RNF213 RFC1 NKIRAS1 ABCC6 OPA1 ABCA5 DYNC1LI1 DNAH11	9.28e-05	848	197	22	IPR027417
Domain	DNA_brk_join_enz	TOP1MT TOP1	1.11e-04	2	197	2	IPR011010
Domain	Clathrin_H-chain_propeller_rpt	CLTCL1 CLTC	1.11e-04	2	197	2	IPR022365
Domain	TopoI_cat_a/b-sub_euk	TOP1MT TOP1	1.11e-04	2	197	2	IPR014727
Domain	TopoI	TOP1MT TOP1	1.11e-04	2	197	2	IPR001631
Domain	TopoI_cat_a-hlx-sub_euk	TOP1MT TOP1	1.11e-04	2	197	2	IPR014711
Domain	TopoI_C_dom	TOP1MT TOP1	1.11e-04	2	197	2	IPR025834
Domain	-	TOP1MT TOP1	1.11e-04	2	197	2	1.10.132.10
Domain	Clathrin-link	CLTCL1 CLTC	1.11e-04	2	197	2	PF09268
Domain	-	CLTCL1 CLTC	1.11e-04	2	197	2	2.130.10.110
Domain	Topoisom_I	TOP1MT TOP1	1.11e-04	2	197	2	PF01028
Domain	TopoI_AS	TOP1MT TOP1	1.11e-04	2	197	2	IPR018521
Domain	Clathrin_heavy_chain	CLTCL1 CLTC	1.11e-04	2	197	2	IPR016341
Domain	DNA_topo_domain1	TOP1MT TOP1	1.11e-04	2	197	2	IPR013034
Domain	TopoI_DNA-bd_mixed-a/b_euk	TOP1MT TOP1	1.11e-04	2	197	2	IPR013030
Domain	-	TOP1MT TOP1	1.11e-04	2	197	2	1.10.10.41
Domain	TopoI_euk	TOP1MT TOP1	1.11e-04	2	197	2	IPR013499
Domain	-	TOP1MT TOP1	1.11e-04	2	197	2	2.170.11.10
Domain	Topo_C_assoc	TOP1MT TOP1	1.11e-04	2	197	2	PF14370
Domain	Clathrin_H-chain_propeller_N	CLTCL1 CLTC	1.11e-04	2	197	2	IPR001473
Domain	Topoisom_I_N	TOP1MT TOP1	1.11e-04	2	197	2	PF02919
Domain	TOPEUc	TOP1MT TOP1	1.11e-04	2	197	2	SM00435
Domain	TopoI_cat_euk	TOP1MT TOP1	1.11e-04	2	197	2	IPR013500
Domain	TopoI_DNA-bd_euk	TOP1MT TOP1	1.11e-04	2	197	2	IPR008336
Domain	-	TOP1MT TOP1	1.11e-04	2	197	2	3.90.15.10
Domain	Clathrin_H-chain_link/propller	CLTCL1 CLTC	1.11e-04	2	197	2	IPR016025
Domain	Clathrin_propel	CLTCL1 CLTC	1.11e-04	2	197	2	PF01394
Domain	Clathrin_H-chain_linker_core	CLTCL1 CLTC	1.11e-04	2	197	2	IPR015348
Domain	TOPOISOMERASE_I_EUK	TOP1MT TOP1	1.11e-04	2	197	2	PS00176
Domain	-	RGPD4 RGPD3 RGPD8	1.31e-04	10	197	3	1.10.220.60
Domain	fn3	IL12RB1 EPHA6 NFASC GHR PTPRH IL31RA CNTN3 ANKFN1	3.29e-04	162	197	8	PF00041
Domain	Clathrin_H-chain_linker	CLTCL1 CLTC	3.30e-04	3	197	2	IPR012331
Domain	CLH	CLTCL1 CLTC	3.30e-04	3	197	2	SM00299
Domain	TPR_REGION	RGPD4 RGPD3 RGPD5 RGPD8 DNAH10 INTS8 TMTC1 PRKDC	3.72e-04	165	197	8	PS50293
Domain	TPR	RGPD4 RGPD3 RGPD5 RGPD8 DNAH10 INTS8 TMTC1 PRKDC	3.72e-04	165	197	8	PS50005
Domain	Dynein_heavy_chain_D4_dom	DNAH10 DYNC2H1 DNAH11	3.86e-04	14	197	3	IPR024317
Domain	AAA_8	DNAH10 DYNC2H1 DNAH11	3.86e-04	14	197	3	PF12780
Domain	EMP24_GP25L	TMED6 TMED4 TMED9	4.79e-04	15	197	3	PF01105
Domain	CH	PARVG SPTBN5 DMD SYNE1 MACF1	6.14e-04	65	197	5	SM00033
Domain	FN3	IL12RB1 EPHA6 NFASC GHR PTPRH IL31RA CNTN3 ANKFN1	7.92e-04	185	197	8	SM00060
Domain	TPR-like_helical_dom	RGPD4 CLTCL1 RGPD3 CLTC RGPD5 RGPD8 INTS8 TMTC1 PRKDC	8.45e-04	233	197	9	IPR011990
Domain	CH	PARVG SPTBN5 DMD SYNE1 MACF1	8.62e-04	70	197	5	PF00307
Domain	-	PARVG SPTBN5 DMD SYNE1 MACF1	9.19e-04	71	197	5	1.10.418.10
Domain	GOLD_dom	TMED6 TMED4 TMED9	9.89e-04	19	197	3	IPR009038
Domain	GOLD	TMED6 TMED4 TMED9	9.89e-04	19	197	3	PS50866
Domain	CH	PARVG SPTBN5 DMD SYNE1 MACF1	1.04e-03	73	197	5	PS50021
Domain	Hyaluronidase	HYAL4 HYAL1	1.08e-03	5	197	2	IPR018155
Domain	Glyco_hydro_56	HYAL4 HYAL1	1.08e-03	5	197	2	PF01630
Domain	CH-domain	PARVG SPTBN5 DMD SYNE1 MACF1	1.18e-03	75	197	5	IPR001715
Domain	FN3	IL12RB1 EPHA6 NFASC GHR PTPRH IL31RA CNTN3 ANKFN1	1.27e-03	199	197	8	PS50853
Domain	Myb-like_dom	EP400 MYPOP	1.61e-03	6	197	2	IPR017877
Domain	FAT	TMTC1 PRKDC	1.61e-03	6	197	2	PF02259
Domain	EF-hand_dom_typ1	DMD DRP2	1.61e-03	6	197	2	IPR015153
Domain	EF-hand_dom_typ2	DMD DRP2	1.61e-03	6	197	2	IPR015154
Domain	PIK-rel_kinase_FAT	TMTC1 PRKDC	1.61e-03	6	197	2	IPR003151
Domain	EF-hand_2	DMD DRP2	1.61e-03	6	197	2	PF09068
Domain	EF-hand_3	DMD DRP2	1.61e-03	6	197	2	PF09069
Domain	FN3_dom	IL12RB1 EPHA6 NFASC GHR PTPRH IL31RA CNTN3 ANKFN1	1.73e-03	209	197	8	IPR003961
Domain	PH_dom-like	RGPD4 ACAP1 MTMR10 SPTBN5 AFAP1L2 RGPD3 RGPD5 CDC42BPA RGPD8 FERMT1 RASAL3 TLN1	1.95e-03	426	197	12	IPR011993
Domain	Clathrin	CLTCL1 CLTC	2.24e-03	7	197	2	PF00637
Domain	CHCR	CLTCL1 CLTC	2.24e-03	7	197	2	PS50236
Domain	ARM-like	MON2 GPRASP1 APC2 MROH5 TARBP1 MROH2A MROH2B LTN1 PRKDC	2.34e-03	270	197	9	IPR011989
Domain	Glycoside_hydrolase_SF	HYAL4 MGAM2 HYAL1 FUCA1	2.35e-03	53	197	4	IPR017853
Domain	-	CPA2 CPB1	2.97e-03	8	197	2	3.30.70.340
Domain	Glyco_transf_10	FUT3 FUT5	2.97e-03	8	197	2	PF00852
Domain	Glyco_tran_10_N	FUT3 FUT5	2.97e-03	8	197	2	PF17039
Pubmed	Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans.	ERVK-6 ERVK-7 ERVK-10 ERVK-24	1.32e-09	4	211	4	10469592
Pubmed	Complex genomic rearrangements lead to novel primate gene function.	RGPD4 RGPD3 RGPD5 RGPD8	4.54e-08	7	211	4	15710750
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	RGPD4 GABRG2 IL12RB1 CLTCL1 PDE10A FASN MDN1 BRCA1 RGPD3 CLTC RETREG1 DLG3 DMD TOP1MT RGPD5 KIF13B HYOU1 RGPD8 SYNE1 PPFIA4 RPL14 MYPOP SETD5 TMEM184C MACF1 PADI6 PRKDC TOP1	6.16e-08	1442	211	28	35575683
Pubmed	Polymorphisms in DNA repair genes, ionizing radiation exposure and risk of breast cancer in U.S. Radiologic technologists.	BRCA1 WRN PRKDC	2.20e-07	3	211	3	17764108
Pubmed	Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.	CLTCL1 ACE FASN MDN1 CLTC CACNA1G HYOU1 DYNC2H1 SYNE1 RPL14 SPAG5 NBAS CS TLN1 MACF1 PCNX1 PRKDC PGM2 TOP1	5.75e-07	807	211	19	30575818
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	CHD1 FASN MDN1 CLTC GNL2 MED23 EIF3M TMEM117 MGAM2 DNHD1 HYOU1 DNAH10 DYNC2H1 SYNE1 LRRC40 RPL14 RFC1 OPA1 CS TLN1 SFXN3 DYNC1LI1 TMED9 PRKDC TOP1 CPSF7	6.20e-07	1425	211	26	30948266
Pubmed	Genomewide screening for fusogenic human endogenous retrovirus envelopes identifies syncytin 2, a gene conserved on primate evolution.	ERVK-6 ERVK-9 ERVK-19 ERVK-8	6.27e-07	12	211	4	14557543
Pubmed	Structural basis of UV DNA-damage recognition by the DDB1-DDB2 complex.	DDB2 SIRT6 DCAF11	8.77e-07	4	211	3	19109893
Pubmed	Human endogenous retrovirus K10: expression of Gag protein and detection of antibodies in patients with seminomas.	ERVK-6 ERVK-10 ERVK-19	8.77e-07	4	211	3	7983737
Pubmed	Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons.	RGPD4 NFASC RGPD3 RGPD8	9.02e-07	13	211	4	31427429
Pubmed	A revised nomenclature for transcribed human endogenous retroviral loci.	ERVK-6 ERVK-7 ERVK-9 ERVK-10 ERVK-19 ERVK-24 ERVK-8	1.79e-06	94	211	7	21542922
Pubmed	Quantitation of HERV-K env gene expression and splicing in human breast cancer.	ERVK-6 ERVK-7 ERVK-19	2.18e-06	5	211	3	12629516
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	MON2 CLTCL1 PTGFRN FASN MDN1 CLTC GNL2 EIF3M HYOU1 LAMB1 RNF213 RPL14 RFC1 NPLOC4 SPAG5 NBAS TLN1 LTN1 CD44 LRP4 DYNC1LI1 TMED9 PRKDC LAS1L MRPL9	2.51e-06	1440	211	25	30833792
Pubmed	Camptothecin resistance is determined by the regulation of topoisomerase I degradation mediated by ubiquitin proteasome pathway.	BRCA1 PRKDC TOP1	4.34e-06	6	211	3	28415827
Pubmed	Human endogenous retrovirus HERV-K(HML-2) proviruses with Rec protein coding capacity and transcriptional activity.	ERVK-6 ERVK-9 ERVK-19	4.34e-06	6	211	3	15063128
Pubmed	Systematic identification of factors for provirus silencing in embryonic stem cells.	RGPD4 MDN1 BRCA1 RGPD3 EIF3M RGPD8 RFC1 LAS1L	4.68e-06	153	211	8	26365490
Pubmed	A High-Density Human Mitochondrial Proximity Interaction Network.	PEX6 SPTBN5 MDN1 CLTC RETREG1 GNL2 WDR62 USP30 HYOU1 RGPD8 SYNE1 AHCTF1 RNF213 LRRC40 RPL14 CCDC51 OPA1 TEFM NBAS CS UQCC3 LAS1L MRPL9 TOP1 CPSF7	4.89e-06	1496	211	25	32877691
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	RGPD4 GPRASP1 CTTNBP2 TBC1D5 APC2 NFASC LRRTM1 MDN1 RGPD3 CLTC DLG3 KIF13B RGPD8 SYNE1 GRIN2D OPA1 SFXN3 MACF1 TMED9	7.47e-06	963	211	19	28671696
Pubmed	Interconversion of red opsin isoforms by the cyclophilin-related chaperone protein Ran-binding protein 2.	RGPD4 RGPD3 RGPD8	7.57e-06	7	211	3	9037092
Pubmed	Nup358, a nucleoporin, functions as a key determinant of the nuclear pore complex structure remodeling during skeletal myogenesis.	RGPD4 RGPD3 RGPD8	7.57e-06	7	211	3	21205196
Pubmed	Differential loss of prolyl isomerase or chaperone activity of Ran-binding protein 2 (Ranbp2) unveils distinct physiological roles of its cyclophilin domain in proteostasis.	RGPD4 RGPD3 RGPD8	7.57e-06	7	211	3	24403063
Pubmed	Kinesin-1 and mitochondrial motility control by discrimination of structurally equivalent but distinct subdomains in Ran-GTP-binding domains of Ran-binding protein 2.	RGPD4 RGPD3 RGPD8	7.57e-06	7	211	3	23536549
Pubmed	Identification of RanBP2- and kinesin-mediated transport pathways with restricted neuronal and subcellular localization.	RGPD4 RGPD3 RGPD8	7.57e-06	7	211	3	12191015
Pubmed	Ranbp2 haploinsufficiency mediates distinct cellular and biochemical phenotypes in brain and retinal dopaminergic and glia cells elicited by the Parkinsonian neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).	RGPD4 RGPD3 RGPD8	7.57e-06	7	211	3	22821000
Pubmed	Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene.	RGPD4 RGPD3 RGPD8	7.57e-06	7	211	3	11353387
Pubmed	Microglial activation in an amyotrophic lateral sclerosis-like model caused by Ranbp2 loss and nucleocytoplasmic transport impairment in retinal ganglion neurons.	RGPD4 RGPD3 RGPD8	7.57e-06	7	211	3	30944974
Pubmed	Nucleoporin Nup358 drives the differentiation of myeloid-biased multipotent progenitors by modulating HDAC3 nuclear translocation.	RGPD4 RGPD3 RGPD8	7.57e-06	7	211	3	38838144
Pubmed	Retina-specifically expressed novel subtypes of bovine cyclophilin.	RGPD4 RGPD3 RGPD8	7.57e-06	7	211	3	7559465
Pubmed	Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate.	RGPD4 RGPD3 RGPD8	7.57e-06	7	211	3	17372272
Pubmed	Proteostatic Remodeling of Small Heat Shock Chaperones─Crystallins by Ran-Binding Protein 2─and the Peptidyl-Prolyl cis-trans Isomerase and Chaperone Activities of Its Cyclophilin Domain.	RGPD4 RGPD3 RGPD8	7.57e-06	7	211	3	38657106
Pubmed	Haploinsufficiency of RanBP2 is neuroprotective against light-elicited and age-dependent degeneration of photoreceptor neurons.	RGPD4 RGPD3 RGPD8	7.57e-06	7	211	3	18949001
Pubmed	Selective impairment of a subset of Ran-GTP-binding domains of ran-binding protein 2 (Ranbp2) suffices to recapitulate the degeneration of the retinal pigment epithelium (RPE) triggered by Ranbp2 ablation.	RGPD4 RGPD3 RGPD8	7.57e-06	7	211	3	25187515
Pubmed	Localization of the Ran-GTP binding protein RanBP2 at the cytoplasmic side of the nuclear pore complex.	RGPD4 RGPD3 RGPD8	7.57e-06	7	211	3	8603673
Pubmed	Uncoupling phototoxicity-elicited neural dysmorphology and death by insidious function and selective impairment of Ran-binding protein 2 (Ranbp2).	RGPD4 RGPD3 RGPD8	7.57e-06	7	211	3	26632511
Pubmed	Distinct and atypical intrinsic and extrinsic cell death pathways between photoreceptor cell types upon specific ablation of Ranbp2 in cone photoreceptors.	RGPD4 RGPD3 RGPD8	7.57e-06	7	211	3	23818861
Pubmed	Neuroprotection resulting from insufficiency of RANBP2 is associated with the modulation of protein and lipid homeostasis of functionally diverse but linked pathways in response to oxidative stress.	RGPD4 RGPD3 RGPD8	7.57e-06	7	211	3	20682751
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	RGPD4 DDB2 FBXO30 FASN RGPD3 CLTC EIF3M WDR62 RGPD5 RGPD8 DYNC2I2 SYNE1 AHCTF1 LAMB1 SPAG5 TMED4 NBAS TLN1 DYNC1LI1 PRKDC DCAF11	8.45e-06	1155	211	21	20360068
Pubmed	The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity.	RGPD4 RGPD3 RGPD8	1.21e-05	8	211	3	21670213
Pubmed	Critical role of RanBP2-mediated SUMOylation of Small Heterodimer Partner in maintaining bile acid homeostasis.	RGPD4 RGPD3 RGPD8	1.21e-05	8	211	3	27412403
Pubmed	Mice lacking Ran binding protein 1 are viable and show male infertility.	RGPD4 RGPD3 RGPD8	1.21e-05	8	211	3	21310149
Pubmed	The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2.	RGPD4 RGPD3 RGPD8	1.21e-05	8	211	3	22262462
Pubmed	Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes.	RGPD4 RGPD3 RGPD8	1.21e-05	8	211	3	28745977
Pubmed	USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.	MDN1 CLTC DMD DNHD1 CDC42BPA RGPD8 SYNE1 RFC1 MACF1	1.44e-05	234	211	9	36243803
Pubmed	Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.	FASN MDN1 MED12L DOCK1 FERMT1 LRRC40 INTS8 TLN1 DYNC1LI1 MACF1 PRKDC LAS1L TOP1 CPSF7	1.46e-05	582	211	14	20467437
Pubmed	Comparative analysis of 1196 orthologous mouse and human full-length mRNA and protein sequences.	CYP21A2 CFTR BRCA1 RB1	1.51e-05	25	211	4	8889551
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	CHD1 SEMA4C MDN1 BRCA1 RGPD3 GNL2 DLG3 MED23 EIF3M USP30 CDC42BPA EP400 SYNE1 AHCTF1 WRN INTS8 TEFM SETD5 TLN1 LTN1 MACF1 TMED9 LAS1L MRPL9	1.52e-05	1497	211	24	31527615
Pubmed	Quantitative Proteomics Reveals Dynamic Interactions of the Minichromosome Maintenance Complex (MCM) in the Cellular Response to Etoposide Induced DNA Damage.	RGPD4 FASN RGPD3 CLTC DMD TOP1MT RGPD5 RGPD8 SYNE1 RNF213 OPA1 NPLOC4 CS TLN1 MACF1 PRKDC TOP1	1.76e-05	844	211	17	25963833
Pubmed	Loss of Ranbp2 in motoneurons causes disruption of nucleocytoplasmic and chemokine signaling, proteostasis of hnRNPH3 and Mmp28, and development of amyotrophic lateral sclerosis-like syndromes.	RGPD4 RGPD3 RGPD8	1.80e-05	9	211	3	28100513
Pubmed	Association of the kinesin-binding domain of RanBP2 to KIF5B and KIF5C determines mitochondria localization and function.	RGPD4 RGPD3 RGPD8	1.80e-05	9	211	3	17887960
Pubmed	The cyclophilin-like domain mediates the association of Ran-binding protein 2 with subunits of the 19 S regulatory complex of the proteasome.	RGPD4 RGPD3 RGPD8	1.80e-05	9	211	3	9733766
Pubmed	Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha.	RGPD4 RGPD3 RGPD8	1.80e-05	9	211	3	18394993
Pubmed	The docking of kinesins, KIF5B and KIF5C, to Ran-binding protein 2 (RanBP2) is mediated via a novel RanBP2 domain.	RGPD4 RGPD3 RGPD8	1.80e-05	9	211	3	11553612
Pubmed	The zinc finger cluster domain of RanBP2 is a specific docking site for the nuclear export factor, exportin-1.	RGPD4 RGPD3 RGPD8	1.80e-05	9	211	3	10601307
Pubmed	Impairments in age-dependent ubiquitin proteostasis and structural integrity of selective neurons by uncoupling Ran GTPase from the Ran-binding domain 3 of Ranbp2 and identification of novel mitochondrial isoforms of ubiquitin-conjugating enzyme E2I (ubc9) and Ranbp2.	RGPD4 RGPD3 RGPD8	1.80e-05	9	211	3	28877029
Pubmed	Transcription factor Foxp3 and its protein partners form a complex regulatory network.	RGPD4 FASN RGPD3 GNL2 RGPD8 AHCTF1 LRRC40 TLN1 DYNC1LI1 LAS1L TOP1	1.82e-05	370	211	11	22922362
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	MON2 FBXO30 DNALI1 EIF3M WDR62 KIF13B DYNC2I2 RB1 DYNC2H1 RADX WRN CCDC51 OPA1 SPAG5 TMED4 TEFM CS SETD5 DYNC1LI1 FUCA1 DCAF11 LAS1L	1.98e-05	1321	211	22	27173435
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	GABRG2 IL12RB1 CTTNBP2 NFASC LRRTM1 FASN CLTC DLG3 DMD HYOU1 SYNE1 PPFIA4 RPL14 OPA1 CS TLN1 SFXN3 SLC4A10 MACF1 TMED9 TOP1 CPSF7 DNAH11	2.22e-05	1431	211	23	37142655
Pubmed	Parkin ubiquitinates and promotes the degradation of RanBP2.	RGPD4 RGPD3 RGPD8	2.56e-05	10	211	3	16332688
Pubmed	The RanBP2/RanGAP1*SUMO1/Ubc9 SUMO E3 ligase is a disassembly machine for Crm1-dependent nuclear export complexes.	RGPD4 RGPD3 RGPD8	2.56e-05	10	211	3	27160050
Pubmed	Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin.	RGPD4 RGPD3 RGPD8	2.56e-05	10	211	3	8857542
Pubmed	Ran-dependent docking of importin-beta to RanBP2/Nup358 filaments is essential for protein import and cell viability.	RGPD4 RGPD3 RGPD8	2.56e-05	10	211	3	21859863
Pubmed	Optimized fragmentation schemes and data analysis strategies for proteome-wide cross-link identification.	CHD1 MDN1 CLTC DMD CDC42BPA HYOU1 LAMB1 RPL14 RFC1 TLN1 MACF1 TOP1 SOD2	2.82e-05	538	211	13	28524877
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	CHD1 FASN MDN1 CLTC DDX43 EIF3M EP400 RB1 AHCTF1 FERMT1 LRRC40 RPL14 RFC1 CS TLN1 SFXN3 LTN1 DYNC1LI1 MACF1 PRKDC LAS1L TOP1	2.84e-05	1353	211	22	29467282
Pubmed	Global genetic analysis in mice unveils central role for cilia in congenital heart disease.	WDR62 DOCK1 NDST1 DYNC2H1 WRN DNAH11	3.44e-05	100	211	6	25807483
Pubmed	The p97/VCP segregase is essential for arsenic-induced degradation of PML and PML-RARA.	FASN MDN1 BRCA1 MED23 RNF213 RPL14 CCDC51 OPA1 LAS1L	3.49e-05	262	211	9	36880596
Pubmed	RanBP2 modulates Cox11 and hexokinase I activities and haploinsufficiency of RanBP2 causes deficits in glucose metabolism.	RGPD4 RGPD3 RGPD8	3.50e-05	11	211	3	17069463
Pubmed	T-cell receptor (TCR) signaling promotes the assembly of RanBP2/RanGAP1-SUMO1/Ubc9 nuclear pore subcomplex via PKC-θ-mediated phosphorylation of RanGAP1.	RGPD4 RGPD3 RGPD8	3.50e-05	11	211	3	34110283
Pubmed	An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age.	RGPD4 RGPD3 RGPD8	3.50e-05	11	211	3	35771867
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	FASN CLTC DOCK1 CDC42BPA WRN NBAS LTN1 PRKDC	3.51e-05	202	211	8	33005030
Pubmed	TRIM29 regulates the assembly of DNA repair proteins into damaged chromatin.	BRCA1 EP400 RFC1 PRKDC	3.64e-05	31	211	4	26095369
Pubmed	Dominant-negative inhibition of Ca2+ influx via TRPV2 ameliorates muscular dystrophy in animal models.	TRPV2 DMD	3.66e-05	2	211	2	19050039
Pubmed	Mitochondrial topoisomerase I is critical for mitochondrial integrity and cellular energy metabolism.	TOP1MT TOP1	3.66e-05	2	211	2	22911747
Pubmed	Structure of the DNA-bound BRCA1 C-terminal region from human replication factor C p140 and model of the protein-DNA complex.	BRCA1 RFC1	3.66e-05	2	211	2	20081198
Pubmed	Functional mammary gland development and oncogene-induced tumor formation are not affected by the absence of the retinoblastoma gene.	BRCA1 RB1	3.66e-05	2	211	2	11704837
Pubmed	Mesenchymal subtype of glioblastomas with high DNA-PKcs expression is associated with better response to radiotherapy and temozolomide.	CD44 PRKDC	3.66e-05	2	211	2	28070830
Pubmed	Human muscle-derived cell populations isolated by differential adhesion rates: phenotype and contribution to skeletal muscle regeneration in Mdx/SCID mice.	DMD PRKDC	3.66e-05	2	211	2	21854253
Pubmed	Lack of mitochondrial topoisomerase I (TOP1mt) impairs liver regeneration.	TOP1MT TOP1	3.66e-05	2	211	2	26305952
Pubmed	[Prevalence of frequent recessive diseases in the Spanish population through DNA analyses on samples from the neonatal screening].	CYP21A2 CFTR	3.66e-05	2	211	2	16238926
Pubmed	SOD2, a Potential Transcriptional Target Underpinning CD44-Promoted Breast Cancer Progression.	CD44 SOD2	3.66e-05	2	211	2	35164076
Pubmed	Mitochondrial topoisomerase I sites in the regulatory D-loop region of mitochondrial DNA.	TOP1MT TOP1	3.66e-05	2	211	2	18826252
Pubmed	TSG-6 produced by hMSCs delays the onset of autoimmune diabetes by suppressing Th1 development and enhancing tolerogenicity.	CD44 PRKDC	3.66e-05	2	211	2	23349496
Pubmed	Dystrophic cardiomyopathy: role of TRPV2 channels in stretch-induced cell damage.	TRPV2 DMD	3.66e-05	2	211	2	25616416
Pubmed	Inhibition of fatty acid synthase attenuates CD44-associated signaling and reduces metastasis in colorectal cancer.	FASN CD44	3.66e-05	2	211	2	22266115
Pubmed	Investigating CFTR and KCa3.1 Protein/Protein Interactions.	CFTR KCNN4	3.66e-05	2	211	2	27092946
Pubmed	Sensitive Monogenic Noninvasive Prenatal Diagnosis by Targeted Haplotyping.	CYP21A2 CFTR	3.66e-05	2	211	2	28844486
Pubmed	The retinoblastoma gene undergoes rearrangements in BRCA1-deficient basal-like breast cancer.	BRCA1 RB1	3.66e-05	2	211	2	22706203
Pubmed	BRCA1 modulates the autophosphorylation status of DNA-PKcs in S phase of the cell cycle.	BRCA1 PRKDC	3.66e-05	2	211	2	25223785
Pubmed	BRCA1-associated growth arrest is RB-dependent.	BRCA1 RB1	3.66e-05	2	211	2	10518542
Pubmed	Down-regulation of FUT3 and FUT5 by shRNA alters Lewis antigens expression and reduces the adhesion capacities of gastric cancer cells.	FUT3 FUT5	3.66e-05	2	211	2	21978830
Pubmed	Expression of human endogenous retrovirus type K envelope glycoprotein in insect and mammalian cells.	ERVK-6 ERVK-19	3.66e-05	2	211	2	9060628
Pubmed	Werner protein is a target of DNA-dependent protein kinase in vivo and in vitro, and its catalytic activities are regulated by phosphorylation.	WRN PRKDC	3.66e-05	2	211	2	11889123
Pubmed	Chondroitin sulfate is a crucial determinant for skeletal muscle development/regeneration and improvement of muscular dystrophies.	DMD HYAL1	3.66e-05	2	211	2	23007393
Pubmed	Serines 440 and 467 in the Werner syndrome protein are phosphorylated by DNA-PK and affects its dynamics in response to DNA double strand breaks.	WRN PRKDC	3.66e-05	2	211	2	24429382
Pubmed	Nonsynonymous Variants in PAX4 and GLP1R Are Associated With Type 2 Diabetes in an East Asian Population.	GLP1R PAX4	3.66e-05	2	211	2	29941447
Pubmed	Increasing LRP4 diminishes neuromuscular deficits in a mouse model of Duchenne muscular dystrophy.	DMD LRP4	3.66e-05	2	211	2	33987657
Pubmed	Methylation determines the extracellular calcium sensitivity of the leak channel NALCN in hippocampal dentate granule cells.	NALCN PRMT7	3.66e-05	2	211	2	31601786
Pubmed	Identification of DDB2 protein as a transcriptional regulator of constitutive SOD2 gene expression in human breast cancer cells.	DDB2 SOD2	3.66e-05	2	211	2	19339246
Pubmed	Pitx2 participates in the late phase of the pathway controlling left-right asymmetry.	PITX2 DNAH11	3.66e-05	2	211	2	9708734
Pubmed	Hyaluronidase and CD44 hyaluronan receptor expression in squamous cell laryngeal carcinoma.	HYAL1 CD44	3.66e-05	2	211	2	16713680
Pubmed	Acceptor specificity of different length constructs of human recombinant alpha 1,3/4-fucosyltransferases. Replacement of the stem region and the transmembrane domain of fucosyltransferase V by protein A results in an enzyme with GDP-fucose hydrolyzing activity.	FUT3 FUT5	3.66e-05	2	211	2	7721776
Interaction	RGPD4 interactions	RGPD4 CFTR RGPD3 RGPD5 RGPD8	1.90e-06	22	196	5	int:RGPD4
Interaction	RGPD2 interactions	RGPD4 CFTR RGPD3 RGPD5 RGPD8	5.61e-06	27	196	5	int:RGPD2
Cytoband	19p13.3	APC2 CIRBP-AS1 TMIGD2 SIRT6 RFX2 FUT3 FUT5	1.19e-04	237	210	7	19p13.3
GeneFamily	Fibronectin type III domain containing	IL12RB1 EPHA6 NFASC GHR PTPRH IL31RA CNTN3 ANKFN1	6.01e-05	160	151	8	555
GeneFamily	Transmembrane p24 trafficking proteins	TMED6 TMED4 TMED9	6.56e-05	10	151	3	1064
GeneFamily	Maestro heat like repeat containing	MROH5 MROH2A MROH2B	8.97e-05	11	151	3	636
GeneFamily	Dyneins, axonemal	DNALI1 DNAH10 DNAH11	3.56e-04	17	151	3	536
GeneFamily	Topoisomerases	TOP1MT TOP1	1.02e-03	6	151	2	1050
GeneFamily	Regulatory factor X family	RFX6 RFX2	1.88e-03	8	151	2	1153
Coexpression	FAN_EMBRYONIC_CTX_EX_4_EXCITATORY_NEURON	SLC26A4 CACNA1G TARBP1 RPS6KL1 SYNE1 PPFIA4 RNF213 ABCA5 SLC4A10 CNTN3	6.92e-07	166	202	10	M39026
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SLC26A4 CFTR NTN1 TMEM117 KIF13B ARSJ ABCA5 DNAH11	5.22e-07	152	204	8	655d47efe0608d729801f1f01668e84c1bc0675f
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	HYAL4 CTTNBP2 CFTR NTN1 TMEM117 WDR97 ABCA5	1.71e-06	124	204	7	1fec6663cea40017438ead397b3bf8b3cdb67e58
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SLC26A4 CFTR NTN1 TMEM117 KIF13B ARSJ ABCA5 DNAH11	1.72e-06	178	204	8	51d2188406f04329311b2efd1108fc36617a860e
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NFASC CFAP92 DYNC2I2 CFAP73 WDR97 ABCA5 BEST4 DNAH11	1.72e-06	178	204	8	3b12db04006db6e94fc45649a4b3a63b92f21a61
ToppCell	3'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TMED6 NFASC LRP1B PITX2 ARSJ DPP10 RFX6 PAX4	2.29e-06	185	204	8	eb78614c4acf8d2ce7874d7e51e16997b76127ef
ToppCell	Control-Endothelial-Endothelial-Artery\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CTTNBP2 PDE10A LRP1B FZD6 ARSJ SPAG5 TMTC1 SLC22A16	2.38e-06	186	204	8	2d3a975d2bf92e18e3410dd413fc9f84831d82de
ToppCell	Nasal_Brush-Epithelial-Ciliated_2\|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X	DNALI1 DNAH10 CFAP73 DYNC2H1 SYNE1 RFX2 BEST4 DNAH11	2.79e-06	190	204	8	9ce7df056bfb24d70db4c3c4a2c57d89115de877
ToppCell	Nasal_Brush-Epithelial-Ciliated_2\|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X	DNALI1 DNAH10 CFAP73 DYNC2H1 SYNE1 RFX2 BEST4 DNAH11	2.79e-06	190	204	8	833481ace2800354712e2ce709d5cdfd0aed3d42
ToppCell	CD8+_Memory_T_cell-CV-7\|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster	MON2 KIF13B HYOU1 AHCTF1 RNF213 NBAS MACF1 PRKDC	2.90e-06	191	204	8	9454f642c3621370fa23640b631301346b300950
ToppCell	Control_saline-Hematopoietic_Erythro-Megakary-Erythro-Mega\|Control_saline / Treatment groups by lineage, cell group, cell type	CLEC1B TRPV2 MED12L KCNN4 SLC22A16 CD44 TOP1 EPB42	3.79e-06	198	204	8	1a39a98beef68e1e6d3adc25270a3336fcc5baf4
ToppCell	Control_saline-Hematopoietic_Erythro-Megakary-Erythro-Mega-Erythroid\|Control_saline / Treatment groups by lineage, cell group, cell type	FBXO30 TRPV2 MED12L KCNN4 SLC22A16 CD44 TOP1 EPB42	3.79e-06	198	204	8	dd80fd9671ee863aebcf4c1023d3e004cc2ee709
ToppCell	Control_saline-Hematopoietic_Erythro-Megakary\|Control_saline / Treatment groups by lineage, cell group, cell type	CLEC1B TRPV2 MED12L KCNN4 SLC22A16 CD44 TOP1 EPB42	3.79e-06	198	204	8	cfc2a860bae883299987d3e374d0476ca20e1bdd
ToppCell	10x5'-Lung-Lymphocytic_T_CD4-T_CD4/CD8\|Lung / Manually curated celltypes from each tissue	ACAP1 DNAH10 CFAP73 FBXO36 ESYT3 ANKFN1 DNAH11	7.82e-06	156	204	7	10d191e29b16cae8238e8df6c0ff38882253f34e
ToppCell	Control-MAIT\|World / Disease group and Cell class	PEX6 MTMR10 TMEM117 DTX1 TMIGD2 ABCA5 SLC4A10	1.04e-05	163	204	7	0ca4b835936b4f82217cbe57210c1dd90986c1d0
ToppCell	E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	IL12RB1 ACAP1 PARVG TRPV2 CAPN3 RASAL3 SFXN3	1.13e-05	165	204	7	0c80abf13409767825ef8a507b498afafa7e89c5
ToppCell	E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	IL12RB1 ACAP1 PARVG TRPV2 CAPN3 RASAL3 SFXN3	1.13e-05	165	204	7	cced77f2d74b07010307d7f4788b8cf3fdaeb91a
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PTH1R NQO2 DPYS SLC5A10 MROH2A ABCC6 PNPLA3	1.42e-05	171	204	7	f5014e3c387fe3118944af392abe10d6b9b0abab
ToppCell	Control-MAIT\|Control / Disease group and Cell class	PEX6 MTMR10 WDR62 TMEM117 DTX1 TMIGD2 SLC4A10	1.48e-05	172	204	7	552bc62e8e8bb0ac1cd0452f4410a3af087787eb
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CYP21A2 PTH1R NQO2 DPYS SLC5A10 ABCC6 FUT3	1.71e-05	176	204	7	1595dbeee336a81e581325d63208ec6262664ee9
ToppCell	5'-Adult-Appendix-Epithelial-Tuft-related-Microfold_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NXPE4 NFASC CIRBP-AS1 MGAM2 CFAP73 FERMT1 PNPLA3	1.91e-05	179	204	7	7aa4137f672dadb3be92009cde6e0ea60a15372d
ToppCell	5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH10 CFAP73 DYNC2H1 WDR97 CNTN3 ANKFN1 DNAH11	1.91e-05	179	204	7	5e5f1cdf4aa66868d45b74ba91e20e848a3cbaff
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SLC26A4 CFTR NTN1 TMEM117 KIF13B ARSJ DNAH11	1.98e-05	180	204	7	cfc8bfbfd3617aabbb49f9730c29b673ca157e74
ToppCell	wk_15-18-Hematologic_Lymphocytic-T_&_ILC-ILCP\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	ACAP1 RETREG1 MED12L TMIGD2 CD44 SLC4A10 DCAF11	2.12e-05	182	204	7	6bd48c5d60a259719f65cacee4b8135247e78fa9
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PTH1R NQO2 DPYS SLC5A10 MROH2A ABCC6 PNPLA3	2.20e-05	183	204	7	84b64cf728629c3af9a8d2ed15b93adf562c54b8
ToppCell	LA-11._Adipocyte\|World / Chamber and Cluster_Paper	LRP1B GHR FASN DPP10 ABCC6 LIPE PNPLA3	2.20e-05	183	204	7	b177be283e1553fb1f69a346f1ba79ad00297fa2
ToppCell	LA-11._Adipocyte\|LA / Chamber and Cluster_Paper	LRP1B GHR FASN DPP10 ABCC6 LIPE PNPLA3	2.20e-05	183	204	7	3f9011976782fa8aa95cdd6f00f07a91094d411b
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CFTR LRP1B DMD DRP2 DNAH10 MROH2A DNAH11	2.28e-05	184	204	7	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CFTR LRP1B DMD DRP2 DNAH10 MROH2A DNAH11	2.28e-05	184	204	7	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CFTR LRP1B DMD DRP2 DNAH10 MROH2A DNAH11	2.28e-05	184	204	7	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	CV-Moderate-7\|Moderate / Virus stimulation, Condition and Cluster	MON2 CLTC AHCTF1 RNF213 NBAS MACF1 PRKDC	2.36e-05	185	204	7	a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f
ToppCell	CV-Moderate-7\|CV / Virus stimulation, Condition and Cluster	MON2 CLTC AHCTF1 RNF213 NBAS MACF1 PRKDC	2.44e-05	186	204	7	8571956890fc9894d766ba294a28e376b4aba428
ToppCell	droplet-Heart-HEART-1m-Neuronal-nan\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CLEC1B RETREG1 KCNN4 DPYS CAPN3 GK5 DNAH11	2.44e-05	186	204	7	fddc6b93f98b10aaf8d4ebc142b46d8213f3129d
ToppCell	droplet-Pancreas\|droplet / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GPRASP1 TMED6 NFASC TRPM5 CPA2 CPB1 RFX6	2.53e-05	187	204	7	5f4df092452d8672bda4059c794e099ba3f5a8fa
ToppCell	COVID-19-kidney-CD-IC-B\|kidney / Disease (COVID-19 only), tissue and cell type	SLC26A4 CFTR NTN1 TMEM117 KIF13B ARSJ DNAH11	2.53e-05	187	204	7	ce05b89860573fe0356102e2998d1ef6d1968034
ToppCell	renal_medulla_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	KANSL1L TBC1D5 MTMR10 DOCK1 CDC42BPA SYNE1 LAMB1	2.71e-05	189	204	7	830d9cd0dd706bce22eb2416f07b2c31c870a05a
ToppCell	3'-GW_trimst-1-SmallIntestine-Hematopoietic-T_cells-LTi-like_NCR-_ILC3\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IL12RB1 ACAP1 PARVG TMIGD2 RASAL3 CD44 SLC4A10	2.80e-05	190	204	7	af39d2a46d9502cec69a69b7e8ffef78fc8311c3
ToppCell	Ciliated-cil-3\|World / Class top	DNALI1 DNAH10 DYNC2H1 SYNE1 FBXO36 RFX2 DNAH11	2.99e-05	192	204	7	4989ebb8812b8af1870599acd932849122c05a29
ToppCell	18-Distal-Immune-Hematopoietic,_T_Cells\|Distal / Age, Tissue, Lineage and Cell class	IL12RB1 ACAP1 PARVG RETREG1 TMIGD2 RASAL3 SLC4A10	2.99e-05	192	204	7	7538c7f63108f357478ea4c5bf27c1f9825b87c7
ToppCell	multiciliated\|World / shred by cell class for turbinate	DNALI1 DNAH10 CFAP73 DYNC2H1 RFX2 BEST4 DNAH11	2.99e-05	192	204	7	0f89ea0deb651ca11531c51ee94e0233608d22ea
ToppCell	IPF-Epithelial-Ciliated\|Epithelial / Disease state, Lineage and Cell class	DMD DNAH10 CFAP73 DYNC2H1 SYNE1 ANKFN1 DNAH11	3.09e-05	193	204	7	ad58f5080e0ba65c845056ea6b79037b636e9c64
ToppCell	moderate-Epithelial-Ciliated\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	DNAH10 CFAP73 DYNC2H1 SYNE1 RFX2 BEST4 DNAH11	3.30e-05	195	204	7	3486eae5fdb062a75a907b896c9d7b396d2aa195
ToppCell	control-Lymphoid-Treg\|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	ACAP1 TMIGD2 RNF213 RASAL3 ABCA5 SFXN3 SLC4A10	3.30e-05	195	204	7	66959ae839eb60a573da06bdd227090ebb5bb9ed
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell\|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ACAP1 DLG3 SYNE1 RNF213 RPL14 ZNF365 RASAL3	3.41e-05	196	204	7	a2db88fad9bbc55685f8e681d120ef38715ca3c4
ToppCell	NS-control-d_0-4-Epithelial-Ciliated\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DNALI1 DNAH10 CFAP73 DYNC2H1 SYNE1 BEST4 DNAH11	3.41e-05	196	204	7	d46ab80554dd3c1cc81e1938ea2acfd5e85c6d2a
ToppCell	NS-moderate-d_0-4-Epithelial-Ciliated\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DNALI1 DNAH10 CFAP73 DYNC2H1 SYNE1 RFX2 DNAH11	3.52e-05	197	204	7	71fea4aa6ce96c7693fa94792d08770622873850
ToppCell	mild-low-quality_cells\|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	GPRASP1 SEMA4C RGPD5 SYNE1 RNF213 GK5 ABCA5	3.52e-05	197	204	7	e4331969bd911d1ebb5453f40a7057297b5389b4
ToppCell	Bronchial-10x5prime-Immune_Lymphocytic-T-T_CD4-CD4\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	TRAV12-1 ACAP1 TMIGD2 RASAL3 SLC4A10 TRAV27 TRAV21	3.52e-05	197	204	7	4bc76958ca12af2dd490d4865de6a92554a14656
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNALI1 DNAH10 CFAP73 DYNC2H1 SYNE1 BEST4 DNAH11	3.52e-05	197	204	7	91637bdeab85024b5a02d1066f76cb803a2d6420
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNALI1 DNAH10 CFAP73 DYNC2H1 SYNE1 BEST4 DNAH11	3.52e-05	197	204	7	22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNALI1 DNAH10 CFAP73 DYNC2H1 SYNE1 BEST4 DNAH11	3.52e-05	197	204	7	3bbf068d2ad8196fbc85d3f311a7c54c9aece856
ToppCell	control-Epithelial-Ciliated\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	DNALI1 DNAH10 CFAP73 DYNC2H1 SYNE1 BEST4 DNAH11	3.52e-05	197	204	7	e453d085182364ca347cbcc9dc995c62c3353016
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNALI1 DNAH10 CFAP73 DYNC2H1 SYNE1 BEST4 DNAH11	3.52e-05	197	204	7	87db09f341e2b20eb6e1c3e917cb5c960387b3e9
ToppCell	control-Epithelial-Ciliated\|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	DNALI1 DNAH10 CFAP73 DYNC2H1 SYNE1 BEST4 DNAH11	3.52e-05	197	204	7	d4e963c1f82996371bf3d63578ee9fce8e00c5a8
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	BRCA1 NTN1 WDR62 FERMT1 SIRT6 WDR97 CNTN3	3.64e-05	198	204	7	d5e125f0c4f41b47d567568d0838adcca7655f6d
ToppCell	kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	KANSL1L CTTNBP2 PTGFRN MED23 EP400 LAMB1 TLN1	3.76e-05	199	204	7	174f6013af6eafa577f84205a62927f2b367fda3
ToppCell	LPS_IL1RA_TNF-Hematopoietic_Erythro-Megakary-Erythro-Mega\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	CLEC1B FBXO30 TRPV2 MED12L KCNN4 SLC22A16 EPB42	3.76e-05	199	204	7	2b754670fe77c2301afcdcfc73a1e52cc0cd1de3
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	MON2 RGPD5 SYNE1 RNF213 GK5 ABCA5 MACF1	3.76e-05	199	204	7	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	LPS_IL1RA_TNF-Hematopoietic_Erythro-Megakary\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	CLEC1B FBXO30 TRPV2 MED12L KCNN4 SLC22A16 EPB42	3.76e-05	199	204	7	f894c88ecc7fd0edca28587801fa59352d10f750
ToppCell	LPS_IL1RA-Hematopoietic_Erythro-Megakary-Erythro-Mega-Erythroid\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	FBXO30 TRPV2 MED12L KCNN4 SLC22A16 TOP1 EPB42	3.88e-05	200	204	7	fa1eaf008b54bdf7bbcdec8134460c5f64490de9
ToppCell	LPS_only-Hematopoietic_Erythro-Megakary-Erythro-Mega-Erythroid\|LPS_only / Treatment groups by lineage, cell group, cell type	FBXO30 TRPV2 MED12L KCNN4 SLC22A16 TOP1 EPB42	3.88e-05	200	204	7	83c4181c083b364f0d3a89ae7a0504781fa9fa9f
ToppCell	LPS_only-Hematopoietic_Erythro-Megakary-Erythro-Mega\|LPS_only / Treatment groups by lineage, cell group, cell type	FBXO30 TRPV2 MED12L KCNN4 SLC22A16 TOP1 EPB42	3.88e-05	200	204	7	f15baf287ec467664c23faa53fdea45257f7b9d0
ToppCell	LPS_only-Hematopoietic_Erythro-Megakary\|LPS_only / Treatment groups by lineage, cell group, cell type	FBXO30 TRPV2 MED12L KCNN4 SLC22A16 TOP1 EPB42	3.88e-05	200	204	7	ce8281c9556a1f64f8ca8a029110077d4ef5b35e
ToppCell	erythropoietic-Polychromatic_Erythroblast\|erythropoietic / Lineage and Cell class	CENPN CLTC DYNC2I2 RFC1 SLC22A16 DCAF11 EPB42	3.88e-05	200	204	7	27056f28328df2a51d5634a7927b7084241e3ca2
ToppCell	PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	IL12RB1 ACAP1 PKDREJ KCNN4 RADX RASAL3	4.76e-05	141	204	6	d3ce2218bfa9750795d920e1ef162ea44efb2e66
ToppCell	390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	RTP4 MED23 DNAH10 ZNF365 PABIR3 DNAH11	5.78e-05	146	204	6	cffa91d76606f74553d81150adbb23b003746316
ToppCell	390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5\|390C / Donor, Lineage, Cell class and subclass (all cells)	TRAV12-1 RTP4 MED23 GK5 ZNF365 PABIR3	6.71e-05	150	204	6	fdbfc8f743cf848978cf0488493f6df60be53982
ToppCell	390C-Lymphocytic-NK_cells-NK_cell_D2\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	CENPN MTMR10 TMEM117 TMIGD2 NBAS SLC4A10	7.22e-05	152	204	6	595afcfa8b161e291fcaf2afc7336bac9b6fae0f
ToppCell	PBMC-Mild-Myeloid-cDC-cDC-cDC_4\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	SWT1 MED12L DOCK1 DNAH10 BEST4 PADI6	7.49e-05	153	204	6	91e9d70a5d3f6fd68c284ed0cc113f03d7d1e10b
ToppCell	PBMC-Mild-Myeloid-cDC-cDC-cDC_4\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SWT1 MED12L DOCK1 DNAH10 BEST4 PADI6	7.49e-05	153	204	6	f17f62646633cf95c810dcd5328978058741b276
ToppCell	Control-Epithelial_airway-Ciliated_cells-Ciliated\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DNALI1 DNAH10 CFAP73 SLC22A16 ANKFN1 DNAH11	7.76e-05	154	204	6	4e3bc24043144143842627cacf6f90dda2228910
ToppCell	Control-Epithelial_airway-Ciliated_cells\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DNALI1 DNAH10 CFAP73 SLC22A16 ANKFN1 DNAH11	7.76e-05	154	204	6	7556a4b2b062da5ae7ec2bbb66e745e7662db628
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Fibroblasts\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CLTCL1 NTN1 DMD DTX1 CCDC51 NUDT6	8.64e-05	157	204	6	f086753b51860e23f1275bd75e8802d2a7d7b70a
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CTTNBP2 CFTR LRP1B DNAH10 MROH2A CNTN3	9.58e-05	160	204	6	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CTTNBP2 CFTR LRP1B DNAH10 MROH2A CNTN3	9.58e-05	160	204	6	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	droplet-Lung-nan-3m-Myeloid-Proliferating_Dendritic\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CENPN MED12L DDX43 IL31RA SPAG5 ESYT3	9.58e-05	160	204	6	8a7a73b0ee1877fe02d47f745d36ae2858b529e1
ToppCell	3'-GW_trimst-2-SmallIntestine-Hematopoietic-T_cells-ILCP\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ACAP1 STIMATE FASN TMIGD2 CD44 DCAF11	9.92e-05	161	204	6	6d9907e2949a742c0933128fde57832a9ca5f77c
ToppCell	facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	EPHA6 LRP1B DPP10 DNAH10 ABCA5 CNTN3	1.03e-04	162	204	6	bf886e22ff2a20353499004b53f25fb9e6574896
ToppCell	E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	LRP1B FASN CLTC DNHD1 ABCC6 PGM2	1.03e-04	162	204	6	e0417f1242edf71934fe62bccc55c4678f7ff4ac
ToppCell	E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	LRP1B FASN CLTC DNHD1 ABCC6 PGM2	1.03e-04	162	204	6	8e0f03fcc25b2ea777e8478fbf771699cf93719c
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-like\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SLC26A4 LRP1B SPAG5 RASAL3 FUT5 ANKFN1	1.06e-04	163	204	6	360cd65decda24853124f33a174f5224d7f3ce23
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-like-AT1_Progenitor\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SLC26A4 LRP1B SPAG5 RASAL3 FUT5 ANKFN1	1.06e-04	163	204	6	b59d9b4f7c9f4e5e2c7783a49a96729dae3a81e5
ToppCell	368C-Myeloid-Dendritic-cDC1\|Dendritic / Donor, Lineage, Cell class and subclass (all cells)	TIGD7 CFAP92 BRCA1 FADS6 LIPE PADI6	1.06e-04	163	204	6	299ac2463b7f58eee419d822a2a2d64b973d87e9
ToppCell	3'-GW_trimst-1-SmallIntestine-Epithelial-epithelial_progenitor_cell-Distal_progenitor\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CFTR PITX2 RETREG1 RFX6 CNTN3 PNPLA3	1.10e-04	164	204	6	ea02ca343b2b28e437304de889e2ae1e315a1197
ToppCell	Healthy_Control-Lymphoid-T-innate_T\|Healthy_Control / Condition, Lineage, Cell class and cell subclass	ACAP1 AFAP1L2 DLG3 DTX1 TMIGD2 SLC4A10	1.13e-04	165	204	6	1ade67229b50fe20eb392262a3e1ee4306b73290
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SLC26A4 CFTR NTN1 TMEM117 KIF13B ARSJ	1.13e-04	165	204	6	dc570154baed59ed109e5369589448e075ba66a9
ToppCell	facs-Heart-LA-24m-Lymphocytic-T_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IL12RB1 ACAP1 PARVG TRPV2 KCNN4 RASAL3	1.21e-04	167	204	6	ed75e9715c795e1cc8e58c8a90ed392569404147
ToppCell	facs-Heart-LA-24m-Lymphocytic-T_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IL12RB1 ACAP1 PARVG TRPV2 KCNN4 RASAL3	1.21e-04	167	204	6	f34b34f531b9ed548ed5701305898092c41b9a9b
ToppCell	Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	GPRASP1 NFASC PDE10A GLP1R RFX6 SLC4A10	1.29e-04	169	204	6	96a2aec9acf8a6f966973c035e5ade456cf47772
ToppCell	390C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	CLEC1B ACE PTH1R RGPD5 CAPN3 ABCC6	1.34e-04	170	204	6	a6fa0cab1fa829ec601fe48306b4c43c83425b04
ToppCell	390C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	CLEC1B ACE PTH1R RGPD5 CAPN3 ABCC6	1.34e-04	170	204	6	b40255eee45eb18b5a297336d7f3845fd8f8aa3b
ToppCell	facs-Lung-EPCAM-18m-Endothelial-Vein_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CLEC1B TARBP1 DOCK1 NMNAT1 LRRC40 BATF2	1.34e-04	170	204	6	12203d4410f38cc933d9f160b5fb76828df94119
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	NFASC NALCN DMD FADS6 TMTC1 CD44	1.34e-04	170	204	6	03044e1436443b28dd39d5ef4fdb25c18e3a7546
ToppCell	Severe-Lymphoid-T-\|Severe / Condition, Lineage, Cell class and cell subclass	RGPD4 ACAP1 SYNE1 RFC1 RASAL3 TRAV27	1.34e-04	170	204	6	5788e1158fde036937d41708e9db3222ca351eb1
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	NFASC NALCN DMD FADS6 TMTC1 CD44	1.34e-04	170	204	6	fa753cc8fbd04e63c9a303da4dc17ee2ce907f92
ToppCell	Ionocyte\|World / Class top	SLC26A4 CFTR ACE TMEM117 ZNF365 ABCC6	1.34e-04	170	204	6	d2e592f2a679e6a8d32f2b752d9a3c493e50ced4
ToppCell	facs-Lung-EPCAM-18m-Endothelial-vein_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CLEC1B TARBP1 DOCK1 NMNAT1 LRRC40 BATF2	1.34e-04	170	204	6	f9decb3bf3bf6d4996b0ac27af768236e116aac5
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	ACAP1 CHD1 SYNE1 RNF213 MACF1 PCNX1	1.38e-04	171	204	6	2e9a20f8980b78325c52065a9c14ab3656267c05
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Hematopoietic-Red_blood_cells-RBC\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ACAP1 TRPV2 RGPD8 SLC22A16 DCAF11 EPB42	1.42e-04	172	204	6	acdc261001f63a8cfce1216ef1e33b4e034b1c11
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Hematopoietic-Red_blood_cells\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ACAP1 TRPV2 RGPD8 SLC22A16 DCAF11 EPB42	1.42e-04	172	204	6	8ccc3459dbdf103c631aa2a0defb8790c06ad6c1
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_acinar_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMED6 RETREG1 NTN1 CPA2 CPB1 LRP4	1.47e-04	173	204	6	c62e3ffed55bbb00dcaef6da0aab8446f3f55085
Drug	oxophoebine	CFTR TOP1MT TOP1	2.65e-06	4	200	3	CID000159317
Drug	lauterine	CFTR TOP1MT TOP1	2.65e-06	4	200	3	CID000073104
Drug	AC1L9QTR	CFTR KCNN4 TOP1MT TOP1	2.71e-06	12	200	4	CID000453215
Disease	Intellectual Disability	APC2 PEX6 FASN BRCA1 MED12L CACNA1G MED23 WDR62 NDST1 SYNE1 GRIN2D SLC4A10 MACF1 ELP2 FUCA1 LAS1L	4.76e-08	447	193	16	C3714756
Disease	Profound Mental Retardation	PEX6 FASN CACNA1G WDR62 NDST1 SLC4A10 ELP2	3.79e-05	139	193	7	C0020796
Disease	Mental Retardation, Psychosocial	PEX6 FASN CACNA1G WDR62 NDST1 SLC4A10 ELP2	3.79e-05	139	193	7	C0025363
Disease	Mental deficiency	PEX6 FASN CACNA1G WDR62 NDST1 SLC4A10 ELP2	3.79e-05	139	193	7	C0917816
Disease	Benign Neoplasm	FASN BRCA1 GLP1R TOP1 SOD2	8.48e-05	68	193	5	C0086692
Disease	Neoplasms	FASN BRCA1 GLP1R TOP1 SOD2	8.48e-05	68	193	5	C0027651
Disease	Malignant neoplasm of breast	ACAP1 APC2 PKDREJ FASN BRCA1 DMD NQO2 EIF3M RB1 DYNC2H1 SYNE1 GRIN2D RFX2 ZNF365 LIPE MACF1 MRPL9 TOP1 SOD2	8.72e-05	1074	193	19	C0006142
Disease	behavioural disinhibition measurement	CTTNBP2 CYP21A2 RTP4 ARSJ DNAH11	1.35e-04	75	193	5	EFO_0006946
Disease	intellectual disability (implicated_via_orthology)	KANSL1L NDST1 RB1 CAPN3 ELP2	1.35e-04	75	193	5	DOID:1059 (implicated_via_orthology)
Disease	Lung diseases	ACE PTH1R PRKDC SOD2 DNAH11	1.63e-04	78	193	5	C0024115
Disease	Malignant Neoplasms	FASN BRCA1 GLP1R WRN TOP1 SOD2	2.03e-04	128	193	6	C0006826
Disease	Colorectal Carcinoma	ACAP1 CFTR APC2 CHD1 FBXO30 DNALI1 DLG3 DMD SYNE1 WRN ABCC6 ABCA5 LAS1L SOD2	2.31e-04	702	193	14	C0009402
Disease	alpha-(1;3)-fucosyltransferase 5 measurement	FUT3 FUT5	2.53e-04	4	193	2	EFO_0021979
Disease	Cerebellar Ataxia	SYNE1 RFC1	4.20e-04	5	193	2	C0007758
Disease	Short rib-polydactyly syndrome, Verma-Naumoff type	DYNC2I2 DYNC2H1	4.20e-04	5	193	2	C0432197
Disease	2,3-dihydroxy-5-methylthio-4-pentenoate (DMTPA) measurement	CYP21A2 PEX6	6.27e-04	6	193	2	EFO_0800111
Disease	Lissencephaly	LAMB1 MACF1	6.27e-04	6	193	2	C0266463
Disease	Microvascular complications of diabetes, susceptibility	ACE SOD2	6.27e-04	6	193	2	cv:CN357508
Disease	Brain Ischemia	IL12RB1 ACE RB1 SOD2	6.50e-04	60	193	4	C0007786
Disease	Cerebral Ischemia	IL12RB1 ACE RB1 SOD2	6.50e-04	60	193	4	C0917798
Disease	L-arginine measurement	CYP21A2 MED23 PRMT7	7.18e-04	27	193	3	EFO_0006524
Disease	stimulant use measurement	CYP21A2 RB1 NBAS	8.00e-04	28	193	3	EFO_0600076
Disease	brain edema (is_marker_for)	KCNN4 SOD2	8.75e-04	7	193	2	DOID:4724 (is_marker_for)
Disease	galactoside 3(4)-L-fucosyltransferase measurement	FUT3 FUT5	8.75e-04	7	193	2	EFO_0021853
Disease	X-23641 measurement	KANSL1L PNPLA3	8.75e-04	7	193	2	EFO_0800854
Disease	alpha-(1,3)-fucosyltransferase 5 measurement	FUT3 FUT5	8.75e-04	7	193	2	EFO_0020136
Disease	phospholipids:total lipids ratio, intermediate density lipoprotein measurement	CYP21A2 PCIF1 MACF1 PNPLA3	9.86e-04	67	193	4	EFO_0008595, EFO_0020946
Disease	peroxisomal biogenesis disorder (implicated_via_orthology)	PEX6 PEX7	1.16e-03	8	193	2	DOID:0080377 (implicated_via_orthology)
Disease	peroxisomal biogenesis disorder (is_implicated_in)	PEX6 PEX7	1.16e-03	8	193	2	DOID:0080377 (is_implicated_in)
Disease	stomach cancer (is_implicated_in)	ACE LRP1B BRCA1 SOD2	1.29e-03	72	193	4	DOID:10534 (is_implicated_in)
Disease	Hypoxemia	CPA2 CS SOD2	1.30e-03	33	193	3	C0700292
Disease	Hypoxia	CPA2 CS SOD2	1.30e-03	33	193	3	C0242184
Disease	Anoxemia	CPA2 CS SOD2	1.30e-03	33	193	3	C0003129
Disease	Anoxia	CPA2 CS SOD2	1.30e-03	33	193	3	C0003130
Disease	chylomicron measurement, triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement	PCIF1 PNPLA3 SOD2	1.42e-03	34	193	3	EFO_0008317, EFO_0008596, EFO_0020947
Disease	lung cancer (is_implicated_in)	CFTR ACE LRP1B SOD2	1.43e-03	74	193	4	DOID:1324 (is_implicated_in)
Disease	pseudoxanthoma elasticum (is_implicated_in)	ABCC6 SOD2	1.49e-03	9	193	2	DOID:2738 (is_implicated_in)
Disease	Duchenne muscular dystrophy (implicated_via_orthology)	DMD DRP2 CAPN3	1.68e-03	36	193	3	DOID:11723 (implicated_via_orthology)
Disease	Odontome	PITX2 LRP4	1.85e-03	10	193	2	C0524730
Disease	Tooth Abnormalities	PITX2 LRP4	1.85e-03	10	193	2	C0040427
Disease	cancer (implicated_via_orthology)	ACAP1 DLG3 TOP1MT RB1 MACF1 TOP1 SOD2	2.00e-03	268	193	7	DOID:162 (implicated_via_orthology)
Disease	progression free survival, response to carboplatin, methylcobalamin deficiency type cblE, ovarian carcinoma	EPHA6 DMD ARSJ	2.12e-03	39	193	3	EFO_0001075, EFO_0004920, GO_0097328, MONDO_0009354
Disease	Jeune thoracic dystrophy	DYNC2I2 DYNC2H1	2.25e-03	11	193	2	C0265275
Disease	cerebral cavernous malformation (implicated_via_orthology)	CDC42BPA RNF213	2.25e-03	11	193	2	DOID:0060669 (implicated_via_orthology)
Disease	autosomal recessive polycystic kidney disease (biomarker_via_orthology)	CFTR ACE	2.25e-03	11	193	2	DOID:0110861 (biomarker_via_orthology)
Disease	Colorectal Neoplasms	CFTR APC2 CHD1 SYNE1 ABCC6 ABCA5 SOD2	2.40e-03	277	193	7	C0009404
Disease	congestive heart failure (implicated_via_orthology)	ACE CS SOD2	2.45e-03	41	193	3	DOID:6000 (implicated_via_orthology)
Disease	Mammary Carcinoma, Human	APC2 FASN BRCA1 NQO2 RB1 DYNC2H1 SYNE1 ZNF365 MRPL9 SOD2	2.52e-03	525	193	10	C4704874
Disease	Mammary Neoplasms, Human	APC2 FASN BRCA1 NQO2 RB1 DYNC2H1 SYNE1 ZNF365 MRPL9 SOD2	2.52e-03	525	193	10	C1257931
Disease	Mammary Neoplasms	APC2 FASN BRCA1 NQO2 RB1 DYNC2H1 SYNE1 ZNF365 MRPL9 SOD2	2.59e-03	527	193	10	C1458155
Disease	chylomicron measurement, very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	PCIF1 PNPLA3 SOD2	2.62e-03	42	193	3	EFO_0008317, EFO_0008596, EFO_0020945
Disease	Neurobehavioral Manifestations	NTN1 NMNAT1	2.69e-03	12	193	2	C0525041
Disease	cleft lip	PTGFRN BRCA1 NTN1 MGAM2 SYNE1 CPA2 ANKFN1	2.76e-03	284	193	7	EFO_0003959
Disease	dilated cardiomyopathy (is_implicated_in)	DMD CS SOD2	2.80e-03	43	193	3	DOID:12930 (is_implicated_in)
Disease	liver cirrhosis (is_implicated_in)	ACE PNPLA3 SOD2	2.80e-03	43	193	3	DOID:5082 (is_implicated_in)
Disease	obesity (biomarker_via_orthology)	ACE GLP1R SIRT6 LIPE PNPLA3	2.87e-03	147	193	5	DOID:9970 (biomarker_via_orthology)
Disease	schizophrenia (is_marker_for)	ACE GRIN2D OPA1	3.00e-03	44	193	3	DOID:5419 (is_marker_for)
Disease	obesity (implicated_via_orthology)	TBC1D5 GNRHR2 MED12L DNAH10 CAPN3 PNPLA3	3.00e-03	215	193	6	DOID:9970 (implicated_via_orthology)
Disease	Breast Carcinoma	APC2 FASN BRCA1 NQO2 RB1 DYNC2H1 SYNE1 ZNF365 MRPL9 SOD2	3.00e-03	538	193	10	C0678222
Disease	breast cancer (is_implicated_in)	ACE BRCA1 NQO2 WRN SOD2	3.13e-03	150	193	5	DOID:1612 (is_implicated_in)
Disease	Short Rib-Polydactyly Syndrome	DYNC2I2 DYNC2H1	3.17e-03	13	193	2	C0036996
Disease	Fulminant Hepatic Failure with Cerebral Edema	GABRG2 PRKDC	3.17e-03	13	193	2	C0751197
Disease	Hepatic Stupor	GABRG2 PRKDC	3.17e-03	13	193	2	C0751198
Disease	adipic acid mesurement	AFAP1L2 DPP10	3.17e-03	13	193	2	EFO_0010455
Disease	Hepatic Encephalopathy	GABRG2 PRKDC	3.17e-03	13	193	2	C0019151
Disease	Hepatic Coma	GABRG2 PRKDC	3.17e-03	13	193	2	C0019147
Disease	chylomicron measurement, very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio	PCIF1 PNPLA3 SOD2	3.40e-03	46	193	3	EFO_0008317, EFO_0008596, EFO_0020943
Disease	Gastrointestinal Stromal Sarcoma	DMD NDST1 RB1	3.62e-03	47	193	3	C3179349
Disease	Osteosarcoma	RB1 WRN RFC1	3.62e-03	47	193	3	C0029463
Disease	Malformations of Cortical Development	WDR62 NDST1	3.68e-03	14	193	2	C1955869
Disease	colonic neoplasm, overall survival	PARVG DPP10	3.68e-03	14	193	2	EFO_0000638, EFO_0004288
Disease	Saldino-Noonan Syndrome	DYNC2I2 DYNC2H1	3.68e-03	14	193	2	C0036069
Disease	Majewski Syndrome	DYNC2I2 DYNC2H1	3.68e-03	14	193	2	C0024507
Disease	Cortical Dysplasia	WDR62 NDST1	3.68e-03	14	193	2	C0431380
Disease	Cardiomyopathy, Dilated	FASN DMD SOD2	3.84e-03	48	193	3	C0007193
Disease	Male sterility	CFTR ACE SOD2	3.84e-03	48	193	3	C0917731
Disease	Male infertility	CFTR ACE SOD2	3.84e-03	48	193	3	C0021364
Disease	Subfertility, Male	CFTR ACE SOD2	3.84e-03	48	193	3	C0848676
Disease	age at menopause	BRCA1 EIF3M FERMT1 OPA1 PRKDC POLG2 SOD2	3.87e-03	302	193	7	EFO_0004704
Disease	metabolite measurement	CLTCL1 CYP21A2 ACE DMD NQO2 DPYS NBAS PCIF1 PNPLA3 FUT3	3.98e-03	560	193	10	EFO_0004725
Disease	apolipoprotein A 1 measurement	TMED6 IQCF1 CYP21A2 STIMATE PEX6 DDB2 MED23 PRMT7 DNAH10 RFX6 PCIF1 MACF1 PNPLA3	4.01e-03	848	193	13	EFO_0004614
Disease	cholestasis (biomarker_via_orthology)	CFTR ACE CD44	4.07e-03	49	193	3	DOID:13580 (biomarker_via_orthology)
Disease	developmental disorder of mental health (implicated_via_orthology)	DLG3 GRIN2D RASAL3	4.07e-03	49	193	3	DOID:0060037 (implicated_via_orthology)
Disease	triglycerides to total lipids in chylomicrons and extremely large VLDL percentage	PCIF1 PNPLA3	4.23e-03	15	193	2	EFO_0022328
Disease	Peroxisome biogenesis disorders	PEX6 PEX7	4.23e-03	15	193	2	C1832200
Disease	coronary artery disease (is_implicated_in)	ACE WRN ABCC6 PNPLA3	4.27e-03	100	193	4	DOID:3393 (is_implicated_in)
Disease	Pancreatic Neoplasm	BRCA1 RB1 CD44 SOD2	4.27e-03	100	193	4	C0030297
Disease	Cardiomyopathy, Familial Idiopathic	FASN DMD SOD2	4.31e-03	50	193	3	C1449563
Disease	Gastrointestinal Stromal Tumors	DMD NDST1 RB1	4.31e-03	50	193	3	C0238198
Disease	Malignant neoplasm of pancreas	BRCA1 RB1 CD44 SOD2	4.58e-03	102	193	4	C0346647
Disease	cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement	CYP21A2 LRP4 MACF1 PNPLA3	4.74e-03	103	193	4	EFO_0008595, EFO_0020944
Disease	behavioural inhibitory control measurement	PDE10A MROH2A	4.81e-03	16	193	2	EFO_0008467
Disease	Polyposis, Adenomatous Intestinal	CD44 SOD2	4.81e-03	16	193	2	C2713442
Disease	Familial Intestinal Polyposis	CD44 SOD2	4.81e-03	16	193	2	C2713443
Disease	ankle brachial index	DMD NBAS	4.81e-03	16	193	2	EFO_0003912
Disease	muscular dystrophy (is_implicated_in)	SYNE1 CAPN3	5.43e-03	17	193	2	DOID:9884 (is_implicated_in)
Disease	Psychoses, Substance-Induced	ACE SOD2	5.43e-03	17	193	2	C0033941
Disease	Moyamoya Disease	RNF213 ABCC6	5.43e-03	17	193	2	C0026654
Disease	Adenomatous Polyposis Coli	CD44 SOD2	5.43e-03	17	193	2	C0032580
Disease	cholesterol to total lipids in chylomicrons and extremely large VLDL percentage	PCIF1 PNPLA3	5.43e-03	17	193	2	EFO_0022232

Protein segments in the cluster

Peptide	Gene	Start	Entry
EKHTWEWQTVEAVAT	TMEM184C	276	Q9NVA4
LNSTLWWERTQEDRV	ABCA5	1626	Q8WWZ7
VTLVVNRWWSQYTSI	BEST4	86	Q8NFU0
ERVEWANKIISQTWP	ESYT3	116	A0FGR9
TAVRAWEFWNLKTLQ	EP400	2191	Q96L91
DRKWWSAVVEERDAQ	EPB42	86	P16452
GVSWDSITLQQWRKA	CFTR	1271	P13569
QWRWRVFDGSITKEN	ACE	1071	P12821
EKLVSLSVQTWWTAL	CTSL3P	91	Q5NE16
WKTFWQSVSKERVAR	FBXO4	31	Q9UKT5
VTTWRFTNIKQWNVN	FERMT1	601	Q9BQL6
NVLVNSQWKSRWCSV	AFAP1L2	361	Q8N4X5
VRRSIDNWTKTQWRQ	DNAH11	1336	Q96DT5
REWVTQATALWTANK	CPA2	181	P48052
KTWSRRWFTIQSNQL	ACAP1	281	Q15027
KAWVSWEQTFNITVT	CFAP92	161	Q9ULG3
LNSNWIAVTSRAEEW	DMD	1656	P11532
QWSRQQVKEELATWL	DNHD1	171	Q96M86
RARNWWVASVDVVEN	QDPR	31	P09417
EAARERTLQWESKWI	CFAP73	221	A6NFT4
RTLQWESKWIQIQNT	CFAP73	226	A6NFT4
TLTSWQREIQTWASQ	CHD1	541	O14646
WTKLWAQSTTWQTRN	CIRBP-AS1	61	Q8TBR5
WVSNTKTVVRWLNRA	DPP10	326	Q8N608
VADKSSLVIQWRDTW	NTN1	571	O95631
RERAWLTWEKVSSVD	RB1	71	P06400
QDNVEREETWLSVWV	RASAL3	296	Q86YV0
SLQLEEWQAKWSVES	PARVG	116	Q9HBI0
IRNFAKNWEQWVVSS	RFX6	346	Q8HWS3
TERQKSWWDAVCTLI	RGPD5	526	Q99666
TERQKSWWDAVCTLI	RGPD8	526	O14715
WWTTDQQLIQVIRSI	CPSF7	91	Q8N684
TSERQFWTVSNKWEV	INTS8	536	Q75QN2
SDKDTVATKIQAWWR	IQCF1	66	Q8N6M8
EWKLQSEIQISHSWE	PABIR3	96	Q6P4D5
LWWNSSEKRVFNIVD	LTN1	1581	O94822
KARKTISDRWESQLW	RADX	671	Q6NSI4
ANTVISEKEDATIWW	PADI6	61	Q6TGC4
QSQETKSLWWERRAF	KANSL1L	906	A0AUZ9
WNDVSFWSIKQSVEK	MDN1	3951	Q9NU22
PTWATKRWVAVLSQD	GNL2	261	Q13823
EVYWTDWRTNTLSKA	LRP1B	1481	Q9NZR2
DTVQRSTQWTTDWAL	MED12L	1531	Q86YW9
WLTTAWVLSVAERQA	KCNN4	216	O15554
FRNSTAAWWKKEIEE	MGAM2	1341	Q2M2H8
LVVKWQSSALDVNTW	IL31RA	341	Q8NI17
TEEKWLSSLENTRWL	MTMR10	361	Q9NXD2
SVWDWSLQFTAKDRT	MTMR10	536	Q9NXD2
AIVVSSLDWVWNLEK	LRRTM1	246	Q86UE6
QGATVSLWETVQKWR	GLP1R	26	P43220
IKDVLVWTNDQVVHW	PPFIA4	1026	O75335
WNTAIQSAIRVQHWK	ARSJ	441	Q5FYB0
QQWAKSEKVRLWEVT	NKIRAS1	136	Q9NYS0
LHVAVTWWSDQVKEE	DPYS	131	Q14117
QVRKWISDWNLTTEK	EIF3M	146	Q7L2H7
WTALDSLQKWASVVR	DYNC1LI1	156	Q9Y6G9
QWRAVQGIRWETKSC	DYNC2I2	51	Q96EX3
EVLKTWSHWSIQIVD	CYP21A2	196	P08686
AFSQRWLAWEVIVTK	PCNX1	1656	Q96RV3
AIRTKWSEATINWNG	MINDY4B	441	A8MYZ0
AVQQWRSEGRTAVWL	NUDT6	81	P53370
QWEKVIRGEETATWI	PDE10A	751	Q9Y233
EWVWVAQARESSNTS	PEX6	221	Q13608
QLVVSGSWDQTVKLW	PEX7	126	O00628
DDVLWLQWVTSQVFT	PNPLA3	381	Q9NST1
EKIVSSSWDGNLRLW	DCAF11	496	Q8TEB1
NEELAQTWKRSEQWA	NPLOC4	536	Q8TAT6
QTWKRSEQWATIEQL	NPLOC4	541	Q8TAT6
SQVIFRWWKISLRSE	FBXO36	31	Q8NEA4
RVQWEKNTTSVWYTS	FUCA1	376	P04066
LINSDTLEWERTQLW	MED23	101	Q9ULK4
TLEWERTQLWALTFK	MED23	106	Q9ULK4
QWLRWDKNSLTLEAV	PGM2	21	Q96G03
AWKQVWSIRVTSTEE	NDST1	446	P52848
TTFAPNRLKIWWQSE	LAMB1	101	P07942
IVVAWLSRAEWDQVT	LAS1L	41	Q9Y4W2
LRKNLAAEWWTSVVV	POLG2	106	Q9UHN1
TAEKQWAETWVLTLA	MON2	1106	Q7Z3U7
WFLATASVDQTVKIW	DDB2	256	Q92466
AAWSQRLQTIWKEEP	NQO2	206	P16083
IDVNWWADSAVTLAR	NBAS	391	A2RRP1
NVARVVVWEWLNEHS	DTX1	21	Q86Y01
TTWVKGQLQELSTRW	MACF1	6736	Q9UPN3
LAWIQWAETTLIQRD	MACF1	6891	Q9UPN3
EDTVRVWFSNRRAKW	PAX4	211	O43316
WEEILQQSLWERVST	OPA1	616	O60313
ETREAWNNVTVWGSR	NFASC	771	O94856
TERQKSWWDAVCTLI	RGPD3	526	A6NKT7
PWITLNSSIQKVNEW	BRCA1	371	P38398
VYEQVNRITWEITWV	FZD6	436	O60353
FKTWWIDGVQEQVRR	ERVK-10	366	P87889
FKTWWIDGVQEQVRR	ERVK-19	366	Q9YNA8
FKTWWIDGVQEQVRR	ERVK-24	366	P63145
FKTWWIDGVQEQVRR	ERVK-6	366	Q7LDI9
FKTWWIDGVQEQVRR	ERVK-7	366	P63130
FKTWWIDGVQEQVRR	ERVK-8	366	P62685
FKTWWIDGVQEQVRR	ERVK-9	366	P63126
FKTWWIDGVQEQVRR	HERVK_113	366	P62684
SWIDQERSWAVATLK	DYNC2H1	3616	Q8NCM8
WRAIQEGANSIVTWL	APC2	1686	O95996
TLEKVINETWAWKNA	HYOU1	856	Q9Y4L1
VVKWNVEDTFSWLRK	PCIF1	311	Q9H4Z3
EVTTTLREWSTIWRQ	DOCK1	91	Q14185
WAIVTVFQILTQEDW	CACNA1G	911	O43497
ATETATKRQETWDWF	CD44	231	P16070
YTRRNTQEWTQEWKE	GHR	86	P10912
TSGRAQVVLSWWDIE	PRMT7	271	Q9NVM4
LNQDKWTRETVQWLL	CD1D	166	P15813
KIVDWALSVWRQLNS	CTTNBP2	1306	Q8WZ74
KEIQSLQAELAWWSR	BATF2	61	Q8N1L9
EEQVSWLSKEWAKRA	CS	131	O75390
GKKVRRQWESWSTED	CRAMP1	156	Q96RY5
EVLRNNELSWLWNSS	HYAL4	241	Q2M3T9
IVVLSWVSFWINKDA	GABRG2	286	P18507
TEENAVWIRIAWGTQ	CENPN	126	Q96H22
INASDDEWWQARLVT	DLG3	536	Q92796
REWVEDTQLWIQQVS	DNALI1	76	O14645
VTLWVESWARNQTEK	IL12RB1	111	P42701
ISWQDLRAVELVKSW	GK5	116	Q6ZS86
AGVVLWVSWENTRTK	HYAL1	316	Q12794
WVSWENTRTKESCQA	HYAL1	321	Q12794
SATNLRFVLEWTWNK	AHCTF1	576	Q8WYP5
WTWNKVVLTKEEFDR	AHCTF1	586	Q8WYP5
AVSRDRTWSLWKKQD	ELP2	631	Q6IA86
SSWQIKEKVWRFSTA	FBXO30	671	Q8TB52
NESSADWREVWALVQ	FASN	1801	P49327
LQTWTVSVNEGRWVR	CAPN3	426	P20807
VAKEEWSQTLWINLN	DNAH10	1276	Q8IVF4
KWETIEAWTQQVATE	CPB1	121	P15086
VEADSWRKENFNITW	DDX43	211	Q9NXZ2
VWNATDTKVLLNWEQ	CNTN3	911	Q9P232
NLSAIQEQWETKWKT	CNST	226	Q6PJW8
VWKQATVASELWEKL	DRP2	201	Q13474
LEVLVQDVVRTSSWW	FADS6	36	Q8N9I5
ERWWEQTDLTKLIIS	LRRC40	76	Q9H9A6
QRSALEWKALSEWVT	LIPE	216	Q05469
WLRTNWISRDAAQKI	EPHA6	86	Q9UF33
NSEDLRWKWASSTIL	MROH5	366	Q6ZUA9
RIQESEQSWQISAWR	MROH2A	751	A6NES4
LLTEEETIINSWFWK	GPRASP1	741	Q5JY77
LSAKTELVAWAVSNW	FUT3	186	P21217
ITEKLWRNALEAWAV	FUT3	256	P21217
VAWAVSNWKPDSARV	FUT5	206	Q11128
VVSAWTKQRNNSWVK	PTGFRN	516	Q9P2B2
RWSEVTRKLEFWVQI	KIF13B	981	Q9NQT8
IAQELNWDESTLWIQ	RTL3	346	Q8N8U3
WTWEQTFQELIQEAK	RTP4	6	Q96DX8
TQWLTADRQTWASIS	HHLA1	316	C9JL84
TERQKSWWDAVCTLI	RGPD4	526	Q7Z3J3
RKTPTVVFWQWVNQS	SFXN3	111	Q9BWM7
TNWIQEKVWLSQEVD	SPAG5	1106	Q96R06
LRADWKQWEDSVFQT	SYNE1	2926	Q8NF91
TTVWQRWTRLRAVAQ	SYNE1	5186	Q8NF91
GVQEWLAQARTTWTQ	SYNE1	6211	Q8NF91
WIIFTVFQNSTKVWS	NXPE4	21	Q6UWF7
IQQRATSTAKTWWDR	CCDC51	71	Q96ER9
QVTQTLQWVVRNWTD	ABCC6	1211	O95255
LQWVVRNWTDLENSI	ABCC6	1216	O95255
LDQWASWLDSVVTQV	RFX2	581	P48378
LLRWLRNWQKSSSED	RFC1	611	P35251
LWRSLSESWEVINSK	RETREG1	146	Q9H6L5
WKSTAVTQWNLVCDR	SLC22A16	136	Q86VW1
LQESNWLDEKTWAVV	PKDREJ	1901	Q9NTG1
ATWNITVQWLAVDIA	GNRHR2	11	Q96P88
NTTEGWENRIRLWTD	SETD5	201	Q9C0A6
DRKLTVLDWQQSDRW	TEFM	186	Q96QE5
TESWWKAFSRQLITE	WRN	1011	Q14191
WTNLTEARVRVWFKN	PITX2	121	Q99697
AEVWWNLVPRKTVSS	SEMA4C	21	Q9C0C4
RHQEIWSILESVWIT	SWT1	751	Q5T5J6
SLWKISDVAWTIQLT	MROH2B	581	Q7Z745
ERKVWELARLVWQSS	SIRT6	31	Q8N6T7
HWEAQITEIIQWVSD	CDC42BPA	816	Q5VT25
PEDSWVSKWQRVSNF	SUPT4H1	66	P63272
RQQDLQTAWSELWEL	SPTBN5	1811	Q9NRC6
QEVAESWWQLRSRAQ	SPTBN5	2446	Q9NRC6
FKTWWIDGVQEQVRR	ERVK-9	366	P63128
NNISREEWEWIQKLS	ANKFN1	646	Q8N957
DDVTFWKWISLNTVA	CLTC	106	Q00610
WKWISLNTVALVTDN	CLTC	111	Q00610
EEVIFWKWVSVNTVA	CLTCL1	106	P53675
IRWVGLSRQKSNEVW	CLEC1B	156	Q9P126
SLSQNRGTVIVERWW	MRPL9	46	Q9BYD2
SESTNQRVLWWSILQ	TMED9	196	Q9BVK6
VSVWKTAAVLKWNRE	RNF213	5191	Q63HN8
WEVDVEKATRWQVGI	TRIML2	306	Q8N7C3
EAATTQENVAWRKNW	UQCC3	66	Q6UW78
ITLWLQRWVEDSNIQ	TRAM1L1	316	Q8N609
EWPRKTQVSLTAVWI	nan	406	Q6ZTK2
WKTVKQNEIWLSRES	TMTC1	456	Q8IUR5
VDQATAWERLRVKWT	TMIGD2	46	Q96BF3
LWLQLSWVWSQRKEV	TRAV12-1	11	A0A0B4J245
FSWEDIVRWTKLLQN	TRPM5	291	Q9NZQ8
LWRQNKIDAVIWVFT	SLC26A4	471	O43511
VQAEIKKSWSRWTLA	PTH1R	466	Q03431
AWQKADINTKWAATR	RPL14	76	P50914
VQIENLTWWTLAQDV	SLC5A10	541	A0PJK1
EVIQEWNLTNIKRWA	TLN1	346	Q9Y490
SRDSTVKVWEADWQI	WDR97	311	A6NE52
KEWRESNISASDIIW	SLC4A10	681	Q6U841
VNWWSTAQSLVIILS	TMED6	201	Q8WW62
SVATDSWSIWKLQKA	TRPV2	651	Q9Y5S1
QWKEVRSDNTVTWLA	TOP1MT	236	Q969P6
VTWLAAWTESVQNSI	TOP1MT	246	Q969P6
QNWSATWTKDSKRRD	SORBS3	101	O60504
TWSVREEQVKQWAAE	RPS6KL1	381	Q9Y6S9
GVRAVSVLVEWQQWE	STIMATE	121	Q86TL2
LKAIWNVINWENVTE	SOD2	201	P04179
SKTRDDWLVSWVQSY	PRKDC	3266	P78527
LNVWDWKKDIVVASN	WDR62	181	O43379
LTSESTNQRVLWWSI	TMED4	186	Q7Z7H5
TNQRVLWWSIAQTVI	TMED4	191	Q7Z7H5
WQIWEQFTSKLTSNQ	ZNF233	106	A6NK53
NQWLWVSDDTVRKAS	USP30	471	Q70CQ3
TLKWQERWPVQESKT	SPTY2D1OS	26	A0A0U1RRN3
EWQRWAESAETRIAT	TRMT12	391	Q53H54
RKTQVWRWQSGNSSD	ZNF365	71	Q70YC4
VITTDWISWDKLNRG	TMEM117	216	Q9H0C3
EWTDVQKKIIPWNSR	TARBP1	1426	Q13395
DKSQWISRIEELRAW	TBC1D5	101	Q92609
SVSILWIQLAWVSTQ	TRAV27	6	A0A087WT01
WIQLAWVSTQLLEQS	TRAV27	11	A0A087WT01
IKSAIFNWAKSWEEV	TIGD7	376	Q6NT04
FNWAKSWEEVKQITI	TIGD7	381	Q6NT04
SWEEVKQITIANAWE	TIGD7	386	Q6NT04
WLQLQWVSSKQEVTQ	TRAV21	11	A0A0B4J279
LSKQDWTNSTIALRW	PTPRH	481	Q9HD43
WKEVRHDNKVTWLVS	TOP1	401	P11387
HDNKVTWLVSWTENI	TOP1	406	P11387
ERIYWTDWQTKSIQS	LRP4	956	O75096
VKKWWTRQLTVESDE	NALCN	1716	Q8IZF0
ITSWKRTGQEVQKRW	MYPOP	66	Q86VE0
RTWEVVGSWEQQTLR	GRIN2D	396	O15399
ELATKNSKWVEVDTW	NMNAT1	71	Q9HAN9
NSKWVEVDTWESLQK	NMNAT1	76	Q9HAN9